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ABSTRACT OF THE DISSERTATION 
 
Accelerating Radiation Dose Calculation with High Performance Computing  
and Machine Learning for Large-scale Radiotherapy Treatment Planning 
 
by 
 
Ryan Thomas Neph 
Doctor of Philosophy in Physics and Biology in Medicine 
University of California, Los Angeles, 2020 
Professor Ke Sheng, Chair 
 
Radiation therapy is powered by modern techniques in precise planning and execution 
of radiation delivery, which are being rapidly improved to maximize its benefit to cancer 
patients. In the last decade, radiotherapy experienced the introduction of advanced methods 
for automatic beam orientation optimization, real-time tumor tracking, daily plan 
adaptation, and many others, which improve the radiation delivery precision, planning ease 
and reproducibility, and treatment efficacy. However, such advanced paradigms necessitate 
the calculation of orders of magnitude more causal dose deposition data, increasing the time 
requirement of all pre-planning dose calculation. Principles of high-performance computing 
and machine learning were applied to address the insufficient speeds of widely-used dose 
calculation algorithms to facilitate translation of these advanced treatment paradigms into 
clinical practice.  
iii 
To accelerate CT-guided X-ray therapies, Collapsed-Cone Convolution-Superposition 
(CCCS), a state-of-the-art analytical dose calculation algorithm, was accelerated through its 
novel implementation on highly parallelized GPUs. This context-based GPU-CCCS approach 
takes advantage of X-ray dose deposition compactness to parallelize calculation across 
hundreds of beamlets, reducing hardware-specific overheads, and enabling acceleration by 
two to three orders of magnitude compared to existing GPU-based beamlet-by-beamlet 
approaches. Near-linear increases in acceleration are achieved with a distributed, multi-GPU 
implementation of context-based GPU-CCCS. 
Dose calculation for MR-guided treatment is complicated by electron return effects 
(EREs), exhibited by ionizing electrons in the strong magnetic field of the MRI scanner. EREs 
necessitate the use of much slower Monte Carlo (MC) dose calculation, limiting the clinical 
application of advanced treatment paradigms due to time restrictions. An automatically 
distributed framework for very-large-scale MC dose calculation was developed, granting 
linear scaling of dose calculation speed with the number of utilized computational cores. It 
was then harnessed to efficiently generate a large dataset of paired high- and low-noise MC 
doses in a 1.5 tesla magnetic field, which were used to train a novel deep convolutional 
neural network (CNN), DeepMC, to predict low-noise dose from faster high-noise MC-
simulation. DeepMC enables 38-fold acceleration of MR-guided X-ray beamlet dose 
calculation, while remaining synergistic with existing MC acceleration techniques to achieve 
multiplicative speed improvements. 
This work redefines the expectation of X-ray dose calculation speed, making it possible 
to apply new highly-beneficial treatment paradigms to standard clinical practice for the first 
time.  
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1 INTRODUCTION 
This year the X-ray celebrates its 125th birthday in the consciousness of humanity. Since 
its discovery by Wilhelm Roentgen in late 1985, the X-ray has become one of the most 
innovative tools in our quest to understand the human anatomy. The years following birthed 
the invention and steady progression of radiographic medical imaging and radiation therapy 
that are still very much relied upon in modern medical diagnosis and intervention. The 
earliest forms of radiation therapy were performed using the novel X-rays for superficial 
treatment of skin conditions and for hair removal, though it wasn’t long before the effects of 
radiation for the treatment of malignancies began to be understood. By 1935, the practice of 
Henri Coutard to protract the delivery of radiation into multiple fractions had gained 
momentum for its healthy tissue-sparing properties.  
These innovations paved the way for more than a century of progress, including the 
invention of the first medical linear accelerator in 1947, computed tomography (CT) imaging 
in 1972, and inverse radiotherapy treatment planning in the late 1980s, leading to the 
creation of both intensity modulated radiation therapy and intensity modulated arc therapy 
in 1995. As the technology surrounding the delivery of therapeutic radiation became more 
precise, so too became the expectation for computational planning and dose estimation 
methods. 
Modern radiotherapy continues to experience radical paradigm shifts. In recent years, 
magnetic resonance imaging (MRI) guided radiotherapy has been steadily replacing CT 
guidance because it offers superior soft tissue contrast compared to CT imaging, doesn’t use 
dose depositing ionizing radiation, enables arbitrary orientation of the imaging plane, and 
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offers real time target visualization, tracking, and radiation gating. Additionally, alternative 
therapies have been investigated that take advantage of the radiation dose deposition 
physics of electrons, protons, and other heavy charged particles to enhance treatment 
precision. The leap to non-coplanar 4π external beam arrangements with more sophisticated 
treatment planning algorithms has been investigated extensively with repeated success in 
improving planning efficiency, treatment outcome, and radiation delivery efficiency. 
As the capabilities of radiation therapy have improved, necessarily, the demand for more 
accurate and faster computational dose modelling to power these state-of-the-art planning 
and delivery paradigms has also risen. Conventional computational techniques for 
calculating dose deposition estimates have steadily improved, however, a pointed trade-off 
between dosimetric accuracy and computational speed has complicated the selection of 
approach for each treatment paradigm. With the dawn of the new revolution in cloud-based 
distributed computing and the unprecedented success garnered by deep learning, a class of 
incredibly flexible machine learning algorithms, it is believed that the next leap forward in 
the field of radiation therapy will be enabled by these technologies. 
Here we investigate the application of both high-performance computing and deep 
learning to affect this marked change in the highly demanding process of dose calculation. 
For many new treatment paradigms, significant improvements to the biological outcome can 
be realized, but the largest hurdle to their wide-spread use remains the difficulty of 
translation to clinically feasible timeframes. By employing these new computational 
techniques to the traditional task of radiation dose calculation we aim to bridge the gap 
between cutting-edge research and clinical practice to provide the best care possible. 
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2 OVERVIEW OF RADIATION THERAPY 
In this chapter a summary of basic principles of radiation dose deposition are first 
presented, including the physical principles by which radiation dose is deposited in matter 
and a basic description of the biological effects of radiation in living cells. Next, the most 
prevalent computational methods for estimating radiation dose are introduced. Finally, an 
overview of the clinical radiation treatment planning process is described. 
2.1 Radiation Dose Deposition Mechanisms 
The therapeutic effects of electromagnetic radiation are derived from a class of radiative 
energy known pragmatically as ionizing radiation for its ability to liberate valence electrons 
from (aka ionize) the matter on which it impinges. The therapeutic benefits of ionization are 
realized directly when an X-ray or γ-ray interacts with the electron cloud of an atom, 
producing recoil electrons that continues to interact with the atomic electrons of critical 
molecules within a cellular body, inducing a biological effect. Another consequence of 
ionizing radiation producing therapeutic benefit is the indirect biological effect caused by 
oxidizing reactions with chemical free radicals that are produced in the cellular environment 
by recoil electrons (liberated during electromagnetic interactions). Particulate radiation can 
also induce biological change but does so in a manner that begins differently from that of 
electromagnetic radiation. Some choices of particulate radiation that are utilized for their 
therapeutic benefits include electrons, protons, and other heavy ions. Due to differences in 
the physics underpinning the interactions of each type of particle, the resulting biological 
effects are also varied in both their magnitudes and distributions within the affected area. 
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The direct and indirect effects of radiation both eventually produce biological changes to 
cellular function. The prevailing explanation for how radiation affects cellular function is by 
induction of DNA damage in the form of single- and double-stranded breaks to the 
polynucleotide strands maintaining the purposeful sequence of amino acid base pairs. 
Damage dealt directly to the base pairs as well as single strand breaks are significantly more 
common than double strand breaks and are more easily repaired due to the availability of 
complementary information from the undamaged strand for reconstruction. By comparison, 
double strand breaks are both much less common and much more difficult for the cell to 
properly repair1. The repair processes for base damage and single strand breaks are quite 
successful and are essentially limited to replicating missing information in the base sequence 
by using the complementary strand as an inverted template. But upon incurring damage to 
both strands, a variety of function-altering and sometimes lethal (to the cell) chromosome 
aberrations can be created during the challenging repair processes.  
 During the application of radiation for medical benefit, it is important that the quantity 
of radiation delivered be monitored and even targeted so that its effects can be understood 
and tailored to the needs of the patient. As such, one useful way to quantify the effects of 
radiation is by the measurement of absorbed radiation dose measured in units of energy per 
unit mass, or Gray (abbreviated as Gy) such that 1 Gy is equal to 1 J/kg. Dose is formally 
defined as “the expectation value of the energy imparted to matter per unit mass at a point.”2 
For a dose of 0 Gy, there are no radiation effect. For reference, many forms of cancer are 
treated with radiation dose equal to anywhere from 10 Gy to 70 Gy in most cases. It should 
be noted that for radiographical applications, the goal is to obtain useful image quality and 
reduce the radiation dose as much as possible, and for therapeutic applications, we are 
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instead intentionally imparting large radiation dose in a precise fashion to specific parts of a 
patient’s anatomy. In the pursuit of this goal, there are many mechanisms by which dose can 
be delivered, each with their advantages and disadvantages as determined with the physics 
by which they are governed. To give the reader a better understanding of these mechanisms, 
those applied most for therapeutic purposes are presented next. 
2.1.1 Electromagnetic Radiation 
Photons (electromagnetic radiation) with energies in excess of approximately 25 eV are 
considered ionizing2. Photons used for clinical purposes, however, typically have energies 
well in excess of 1 keV with energies of approximately 100 keV being preferred for 
radiological uses, and energies greater than 2 MeV for therapeutic uses. Clinical photons are 
typically generated using electronic equipment (and are called X-rays) or during the decay 
of radioactive isotopes in their pursuit of nuclear stability (and are called γ-rays). The 
interactions that photons have with matter, regardless of the mechanism of their production, 
can be categorized by one of Rayleigh scattering, photoelectric effect, Compton effect, and 
pair production, listed in the order of their occurrence probabilities with increasing photonic 
energy. Interactions that assume the form of Rayleigh (coherent) scattering result in a 
change to the photon’s propagation direction with essentially no loss of energy; they don’t 
contribute dose to the interaction medium and are consequently neglected from 
consideration in dosimetric analysis and from further description in our presentation.  
2.1.1.1 The Photoelectric Effect 
Primarily exhibited in high-atomic-number media and at low photon energies, the 
photoelectric effect occurs when the energy of photon is completely absorbed by an atom 
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and is subsequently transferred to one of its bound electrons. The excited electron escapes 
from its atomic orbit with kinetic energy (𝑇) effectively equal to the difference between the 
original photon energy (ℎ𝜈) and the binding energy of its orbital shell (𝐸𝑏), neglecting the 
minuscule energy transferred to the recoiling atom, as in Equation 2-1. 
𝑇 = ℎ𝜈 − 𝐸𝑏 
Equation 2-1 
 Following electron emission, the atom is left with an orbital vacancy to be filled by an 
outer-shell electron of higher binding energy, resulting in emission of a characteristic photon 
of discrete energy equal to the difference in the orbital binding energies, or as one or more 
Auger electrons as necessary for the enforcement of energy conservation. The possibility for 
photoelectric interaction to occur with any atomic electron depends on the requirement that 
the photon energy must exceed the binding energy of that electron’s orbital shell. The 
photoelectric effect is the primary physical process by which image contrast is generated for 
radiographical applications due to the high dependence of the process’s interaction 
probability on the atomic number of a medium. 
2.1.1.2 The Compton Effect 
For photons of comparatively higher energy and lower atomic number, the Compton 
effect takes over for the photoelectric effect as the dominant photonic interaction process. 
The Compton effect describes the transfer of some of a photon’s energy to free electron 
resulting in both the emission of an electron and energy loss accompanying a direction 
change for the incident photon. The so-called Compton electron emitted in this interaction 
has, by conservation of energy, a kinetic energy (𝑇) equal to the difference in the incident 
(ℎ𝜈) and scattering (ℎ𝜈′) photon energies, as in Equation 2-2. 
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𝑇 = ℎ𝜈 − ℎ𝜈′ 
Equation 2-2 
The full kinematics describing the Compton effect are derived from joint application of 
the principles of energy and momentum conservation, and while they will not be presented 
here, provide the analytical tools for characterizing the probabilities of observing each of the 
possible outcomes of the Compton effect. These cross-sections are best characterized by the 
Klein-Nishina model3 and are critical for the success of one class of dose estimation methods 
that employs this probabilistic understanding. The Compton effect is the dominant process 
on which the therapeutic application of radiation is founded. 
2.1.1.3 Pair Production 
Photons at even higher energies exhibit lower probabilities of both photoelectric and 
Compton interactions, giving rise to the dominance of another effect called pair production. 
Aptly named, pair production explains the emission an electron-positron pair from the 
complete absorption of a photon in the Coulomb field near an atom’s nucleus or under rarer 
circumstances in the field of an atomic electron where a third product (the excited atomic 
electron) is also emitted and the process is instead called triplet production). In pair 
production, some of the energy of a photon is converted into mass in the form of the electron-
positron pair and the remainder is given to these particles as kinetic energy. Due to the 
creation of these product particles, the minimum photon energy necessary for pair 
production is twice the rest energy of an electron (2𝑚𝑒𝑐
2 = 1.022 𝑀𝑒𝑉), and the photon 
energy exceeding this production threshold is randomly divided amongst each of the 
interaction products. The electron and positron both proceed to interact with the medium 
as will be described in the next section. However, when the positron’s kinetic energy reduces 
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enough, it finally combines with a nearby free electron in a process called positron 
annihilation, that converts mass into energy in the form of two opposed photons, each with 
≥0.511 MeV of energy, that proceed to interact further with the medium. Though less 
evident, pair production explains a non-negligible component of the dose deposited from 
therapeutic applications of ionizing electromagnetic radiation. 
2.1.2 Particulate Radiation 
The interaction processes of charged particles at therapeutic energies (traditionally 
much less than 100 MeV) are somewhat simpler than the dose-depositing processes of 
electromagnetic radiation. Charged particles interact with nearby atoms through the 
Coulomb force experienced in the electric field of either an atomic electron or an atom’s 
nucleus. In the presentation of these interactions by Attix, they can be broadly classified by 
the ratio of the “classical impact parameter 𝑏  vs. the atomic radius 𝑎 ,” into one of three 
groups: “soft collisions (𝑏 ≫ 𝑎)”, “hard (or ‘knock-on’ collisions (𝑏 ~ 𝑎)”, or “Coulomb-force 
interactions with the external nuclear field (𝑏 ≪ 𝑎)”.  
Soft collisions occur when the distance between the charged particle and atom is 
considerably larger than the atomic radius; a very small amount of energy is transferred 
from the particle to the atom as the particle interacts with the entire atom’s electric field. 
Though it may seem insignificant, the high probability for soft collisions leads to a significant 
transfer of energy to the medium on the aggregate. Hard collisions result from the interaction 
of charged particles with an individual orbital electron bound to a nearby atom. The 
significant transfer of kinetic energy to a single electron results in ejection of the bound 
electron as a δ-ray (delta ray), and an energy conserving loss to the incident charged particle. 
The now-vacant space in the atom’s electron cloud is resolved by subsequent emission of a 
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characteristic photon or Auger electrons. For a charged particle passing within a few atomic 
radii of an atom, the probability of Coulomb-force interactions with the atom’s nucleus 
increases. In more than ~97% of such interactions, the result is an insignificant energy loss 
and elastic scattering of the charged particle, altering its trajectory; for these no dose is 
absorbed by the medium. However, for the remaining ~3% of such interactions, the charged 
particle experiences an inelastic collision, losing energy in the process to the creation of a so-
called bremsstrahlung X-rays; it is through this process that X-rays are produced for photon-
based radiation therapy. The yield of bremsstrahlung X-rays is proportional to the square of 
the atomic number of the interacting atoms, and inversely proportional to the inverse 
squared mass of the incident charged particle and is consequently negligible for heavy 
charged particles such as protons and heavy ions. 
Although the interactions of individual charged particles with matter follow a stochastic 
process, it is useful to describe them as a population using the expectation values of energy 
loss per unit path length (stopping power) and propagation distance (range) as a function of 
the particle energy and properties of the interaction medium. This treatment is called the 
continuous slowing down approximation (CSDA). The stopping power of a particle obeys an 
inverse square dependency on the velocity of the incident particle, which gives rise to a 
rapidly increasing rate of energy loss (and dose deposition) for charged particles as they 
approach the end of their flight paths. This sharp increase in dose deposition rate is called 
the Bragg peak, and it is of great interest for therapeutic applications of radiation for its 
reduction in entrance dose to healthy tissues on its way to irradiating a precisely targeted 
region of the patient anatomy. 
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2.1.2.1 Electrons 
Electrons are negatively charged particles with a mass more than 1,800 times smaller 
than that of protons. Due to their small mass, they experience a significantly larger degree of 
multiple scattering as they interact with the electric fields of nearby atomic nuclei than do 
the much heavier protons and heavy ions, causing them to follow very jagged paths through 
media with high atomic number. Furthermore, due to the inverse square dependence of 
bremsstrahlung X-ray yield on the incident particle’s mass, electrons are much more efficient 
for use in generating Bremsstrahlung radiation for therapeutic use than other charged 
particles, forming the operational foundation of modern medical linear accelerators (linacs). 
Most of the energy lost by electrons in media is deposited as dose through the excitation and 
ionization of atomic electrons during soft and hard collisions. Emission of secondary 
radiative products such as δ-rays, Auger electrons, bremsstrahlung, and characteristic X-
rays may also contribute non-negligible dose by spreading energy to surrounding media. 
Some of the electromagnetic radiation produced through such secondary processes escapes 
the target media entirely in the form of radiative losses. Due to the high degree of scattering 
experienced by electrons, their Bragg peaks are substantially diffuse, diminishing their 
beneficial effects in therapeutic application. Another consequence of their tendency for 
scattering, the range of electrons in water and soft tissue is quite small, limiting their clinical 
application to more superficial targets.  
2.1.2.2 Protons and Heavy Ions 
Heavy charged particles are significantly less effective in their ability to produce 
Bremsstrahlung X-rays, but their high masses preserve the sharp gradient in stopping power 
that they exhibit at their Bragg peaks. This property makes heavy charged particle therapies 
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effective at achieving highly precise conformal dose to a targeted volume of tissue. Unlike 
photons (and to a lesser extent electrons), such heavy charged particles deposit very little 
entrance dose before the Bragg peak, where they still have high energies, and nearly zero exit 
dose after the Bragg peak, due to their pointed loss of energy within the Bragg peak. Despite 
their advantageous dose deposition properties, heavy charged particles have caveats to 
clinical use, including the difficulty involved in generating them using a large cyclotrons or 
synchrotrons, and the necessity for precise patient alignment before treatment resulting 
from the highly local dose deposition of dose in the Bragg peak. 
2.1.2.3 Electromagnetic Field Effects 
When any moving charged particle is subjected to an electromagnetic field, the Lorentz 
force induces a force (𝐅) on the charged particle equal to the sum of the electric field (𝐄) 
strength and the vector product of the particles velocity (𝐯) with the strength of the magnetic 
field (𝐁), scaled by the charge of the particle (𝑞), as given in Equation 2-3. A bold emphasis 
denotes a vector quantity. 
𝐅 = 𝒒(𝐄 + 𝐯 × 𝐁) 
Equation 2-3 
In radiation therapy, the electric field component of Equation 2-3 is often small enough 
to be excluded from discussion. However, for charged particles in the strong magnetic field 
of an MRI scanner, the magnetic field component of the Lorentz force can lead to substantial 
changes in the deposition of radiation dose. 
Two macroscopic effects are observed in the dose from X-rays4. First, as charged particles 
are liberated within homogeneous media (through the photoelectric, Compton, and pair 
production interactions), their momenta are altered by the Lorentz force, resulting in an 
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asymmetrical dose penumbra and reduced build-up distance. Second, near the interface 
between high and low density media, the liberated charged particles exit the high density 
medium, follow arc-shaped trajectories in the low density medium, due to the vector product 
component of the Lorentz force, and return back to the high density medium to deposit dose 
near the interface5,6. From Equation 2-3, it is clear that the Lorentz forces produce an effect 
on dose that is dependent on the strength of the magnetic field, but the mass of the charged 
particle is also an important factor; the acceleration of the particle is inversely proportional 
to its mass for a given induced Lorentz force. From this relationship, the small mass of the 
electron punctuates its importance in the X-ray dose deposition process, inspiring the use of 
the term electron return effect (ERE) when referring to this class of dosimetric perturbation. 
2.2 Dose Calculation Algorithms 
Computational dose calculation is a critical component of clinical radiation therapy 
because it enables the creation of safe and effective radiation delivery treatment plans 
without the need for physical (and often impossible) dose measurement to be performed for 
each patient. Dose calculation describes the process by which the three-dimensional (3D) 
voxelized dose within some geometry is algorithmically estimated as a result of a pre-
determined delivery of ionizing radiation. Dose calculation is the procedure responsible for 
providing causal knowledge of how manipulation of the radiation delivery process will affect 
the delivered dose and is a requirement of every method for treatment planning. There exist 
many approaches to dose calculation that each strike a balance between the computational 
speed and the dosimetric accuracy achieved. There is not one method that claims superiority 
over all others. Rather, some methods are well-suited to some purposes, and other methods 
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better suited for other purposes, emphasizing the importance of the selection of dose 
calculation method to the task at hand. In the following sections, the most widely used dose 
calculation methods along with their advantages and disadvantages for certain applications 
will be introduced. 
2.2.1 Monte Carlo Dose Calculation 
The most general technique for dose calculation is to simulate the interactions of 
individual units of electromagnetic and particulate radiation and virtually “measure” the 
resulting dose to a voxelized geometry. These simulation-based methods are named after the 
wider class of Monte Carlo algorithms in which random samples are repeatedly drawn from 
interesting domain-specific probability distributions to obtain numerical results. In the 
context of radiation dose calculation, the interesting probability distributions come from the 
interaction cross sections that are constructed from physical principles and experimental 
findings. Using a virtualized model of an actual radiation source, particles (or photons) are 
instantiated one-by-one and tracked through a virtual geometry in discrete “steps”, with 
their phase space parameters (positions and momenta) updated after each step according to 
random samples from a probability density function corresponding to the type of interaction 
undergone during the step, which is randomly sampled from the interaction cross-section 
model. Using this stochastic simulation strategy, the dose gradually converges to a solution 
with increasing certainty. 
Since Monte Carlo dose calculation techniques are based on well-established physical 
principles of particle transport, they are considered the gold standard for dosimetric 
accuracy, but they require significantly longer computation than deterministic methods to 
attain reasonable levels of certainty in their solutions. This makes Monte Carlo dose 
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calculation difficult to apply in the clinical setting where limitations on dose calculation and 
treatment planning times are often in effect. Many modifications to accelerate the Monte 
Carlo dose calculation have been proposed such as Macro Monte Carlo (MMC)7, condensed 
history8, variance reduction9–11, and hardware-enabled parallelization12–16, but increasing 
Monte Carlo simulation speed still remains of great interest for clinical application. 
2.2.2 Analytical Dose Calculation 
Analytical approaches to dose calculation share the property that they provide a 
deterministic solution to the problem of dose estimation that produces consistent results 
and algorithmic run-times across independent evaluations for the same inputs. Despite their 
deterministic nature, analytical approaches often provide some means of adjusting the 
speed-accuracy trade-off such as by adjusting the spatial dose resolution. By far the most 
popular form of analytical X-ray dose calculation is achieved by efficient convolution of an 
analytically defined volume of voxelized TERMA (total energy released in matter) by a set of 
pre-computed dose deposition kernels17. Each kernel is calculated such that it describes the 
spatial distribution of dose deposition resulting from a single electromagnetic interaction in 
a homogeneous medium (typically water or soft tissue). Kernels are defined for 
monoenergetic X-ray beams using Monte Carlo simulation and can either be represented 
numerically, or more efficiently as analytical functions fit to the numerical simulation results. 
In order to calculate the dose of polyenergetic X-ray beams, the doses resulting from 
convolution monoenergetic by multiple monoenergetic dose kernels are combined by 
weighted addition in a process called convolution-superposition (C/S)18. Inclusion of more 
dose kernels in CS intuitively produces more accurate dose but at higher computational cost.  
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Within the C/S classification, there exist several sub-classes that differ in their choices of 
model for the dose kernels. Pencil beam convolution (PBC) is a fast C/S method where 2D 
dose kernels (pencil beams) are convolved with TERMA only along the transverse axes. 
Varian’s Analytical Anisotropic Algorithm (AAA)19 is a more accurate extension to PBC that 
further implements transverse kernel scaling via radial exponential functions to account for 
the lateral inaccuracies of PBC in heterogeneous media. Collapsed-cone convolution-
superposition (CCCS)20 is yet another approach that accelerates 3D C/S by concentrating all 
the dose spread within radially diverging cones onto each cone’s central axis. The CCCS 
assumption has the effect of reducing the number of kernel parameters and shortening the 
convolution time at the expense of additional approximation to the resulting dose. With the 
addition of corrections for kernel tilting and hardening21, and anatomical heterogeneity by 
kernel scaling along each cone’s axis,22,23 CCCS is generally regarded as more accurate than 
both AAA and PBC, but due to its higher computational cost, hasn’t seen universal adoption 
for clinical use24. 
2.2.3 Linearized Boltzmann Solvers 
Another class of iterative algorithm for explicitly solving the linearized Boltzmann 
transport equation (LBTE) – “the governing equation which describes the macroscopic 
behavior of radiation particles … as they travel through and interact with matter”25 – has 
seen advancement over the last decade26–30. Unlike both the MC simulation and C/S methods, 
LBTE solvers employ iterative numerical algorithms that converge upon the “correct” dose 
based on some pre-defined stopping criteria on the desired accuracy. As in Monte Carlo dose 
calculation, the accuracy of LBTE solvers is dependent on the calculation time. However, 
unlike in Monte Carlo, LBTE solvers exhibit error that is systematic, resulting from 
16 
discretization of calculation parameters, rather than as statistical noise. LBTE solvers show 
promise for dose calculation of treatments with high beam counts because the solution time 
is weakly dependent on the number of radiation sources. Unfortunately, the linearizing 
assumption of the Boltzmann transport equation employed by LBTE solvers is invalid for 
particles experiencing the effects of an external magnetic field, disqualifying them from use 
in the emerging paradigm of MR-guided radiotherapy. 
2.3 Radiation Treatment Planning 
The goal of radiation therapy is to induce death or disturb the reproductive capacity of 
cells in a targeted volume, often cancerous in nature, while preserving the normal function 
of surrounding healthy tissues composing our vital organs. The standard practice for 
achieving 3D conformal radiotherapy (3DCRT), in which radiation is precisely delivered to a 
target volume informed by 3D imaging data, for many anatomical sites is external beam 
radiotherapy (EBRT). EBRT combines multiple beams of radiation generated using external 
sources and focused on the target volume to simultaneously achieve homogeneous dose 
within, and minimal dose beyond the target boundaries. An early method for accomplishing 
3DCRT prescribed the use of fully conformal beams that each delivered a homogeneous 
fluence with a cross-sectional beam shape matching the projection of the target volume from 
advantageous angles of entry (termed the beams-eye-view (BEV)) into patient. To facilitate 
shaping of each beam, the multi-leaf collimator (MLC) was developed31. The MLC provides 
two opposed banks of radiation attenuating tungsten leaves that can be individually 
positioned to shape the beam32. 
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Following this innovation in beam shaping hardware, an advanced technique called 
intensity-modulated radiotherapy (IMRT) was developed33 to increase dose conformality in 
a target volume. IMRT divides the delivery of radiation for each beam into a set of fields, each 
with homogeneous fluence, such that their sum generates more complex shaping of dose for 
greater precision of delivery. The individually positioned leaves of the MLC can be 
mathematically represented as a discrete grid, dividing the total field-of-view (FOV) of a 
beam into component beamlets, for which separate radiation fluence can be delivered; this 
grid of per-beamlet fluence is referred to as the fluence map of the beam and its definition is 
the goal of inverse treatment planning used in modern radiotherapy. 
2.3.1 Beamlet Dose Calculation 
Beamlet dose calculation produces causal information linking the choice of individual 
beamlet fluence to the resulting dose deposited in the patient. To create IMRT treatment 
plans with complex dose modulating fluence maps, this causal dose information must be 
calculated for every beamlet involved in the eventual radiation delivery, the number of 
which can easily reach into the tens or hundreds of thousands34. The requirement for such 
large quantities of dose data severely limits the computational time that can be afforded to 
the pre-planning beamlet dose calculation procedure in clinical settings. Concurrent with the 
efficiency considerations of beamlet dose calculation, are the concerns for dosimetric 
accuracy. Although fast analytical methods exist for many treatment paradigms, such as PBC 
for X-ray therapy, the sacrificed quality of dose they provide is evident in the outcome of 
treatment planning35, resulting in sub-optimal treatment efficacy due to the lack of accurate 
causal information provided to the treatment planning algorithm. Highly accurate 
approaches to dose calculation, such as MC simulation and LBTE solvers are attractive in this 
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regard but fail to even remotely meet the efficiency requirements of the very large scale 
(VLS) beamlet dose calculation tasks required by advanced treatment modalities. This 
highlights the difficulty and importance of selecting the optimal balance of accuracy and 
speed for beamlet dose calculation. 
2.3.2 Inverse Treatment Planning 
Treatment planning for radiation therapy is enabled by mathematical optimization 
techniques that iterate through potential plans to accomplish well-defined goals encoded as 
an objective function. The term inverse planning is used to describe this process since our 
planning goal is an effective and conformal dose distribution, but the machine parameters 
must instead be defined to indirectly affect the eventual dose delivery. Equation 2-4 shows 
a simple form of an optimization problem that is used for beamlet-based inverse planning. 
minimize
𝑓
 ‖𝐴𝑓 − 𝑑0‖2
2
subject to 𝑓 ≥ 0
 
Equation 2-4 
In this problem formulation, the goal is to select a value for the vector 𝑓 ∈ ℝ𝑁 , which 
encodes a plan’s fluence maps, such that the estimate of the deliverable volumetric dose 
distribution computed as 𝐴𝑓 agrees with the dose distribution prescribed by the physician 
and encoded as 𝑑0 ∈ ℝ
𝑀 , with 𝑀 defining the size of volumetric dose, and 𝑁 defining the 
number of beamlets in the plan. For convex inverse planning problems like Equation 2-4, 
simple iterative gradient-based optimization algorithms such as the well-known gradient 
descent algorithm, are used for determining the optimal value of 𝑓 . However, to further 
improve the biological efficacy of clinical treatment plans, more complex mathematical 
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terms are often included36–44, requiring the use of more sophisticated optimization 
algorithms45,46 and greater computation time.  
The primary goal of treatment planning is to select 𝑓  such that the voxels contained 
within the planning target volume (PTV) all receive the physician-prescribed radiation dose, 
while the remaining voxels, belonging to healthy tissues, called organs at risk (OARs), receive 
as little dose as possible. As a consequence of the physics of dose deposition, it is generally 
impossible to achieve perfectly conformal PTV dose while completely sparing OARs, so a 
balance must be struck based on the radiation tolerances and relative positions of the OARs 
to the PTV. Although there are many aspects to inverse treatment planning that must be 
considered, it is important to remember that the outcome of any treatment planning 
algorithm is fundamentally limited in its ability to produce effective outcomes by the quality 
of the dosimetric information it has available to it, determined during beamlet dose 
calculation. 
2.3.3 Final Dose Calculation 
After inverse treatment planning is used to determine the optimal radiation delivery 
parameters, the plan must be evaluated for its safety and efficacy before treatment can begin. 
Plan evaluation uses a final dose calculation procedure in which the effects of radiation from 
all beams are analyzed holistically rather than at the component beamlet-level (as in beamlet 
dose calculation). This distinction generally relaxes, somewhat, the requirements for speed 
in favour of increased dosimetric accuracy. Highly accurate algorithms like MC and LBTE 
solvers, for which the computational speed is independent of or only weakly dependent on 
the number of beamlets in the plan (when their dose can be immediately combined), are 
especially useful for final dose calculation. The clinical implementations of end-to-end dose 
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calculation and treatment planning software almost always include separate strategies for 
beamlet and final dose calculation to best accomplish the goal of fast and effective 
radiotherapy, but the details of both strategies are still evolving with the invention of cutting-
edge techniques that push the capabilities of dose calculation to new limits. 
2.3.4 Online Adaptive Radiotherapy 
With the new capabilities made possible by MR-guided radiotherapy, such as enhanced 
soft tissue image contrast, daily on-board imaging and real-time target tracking, online 
adaptive radiotherapy (OART) is closer to widespread clnical feasibility than ever before. 
With OART, daily changes to the shapes and locations of the planning target volume(s) and 
organs-at-risk are visualized and compensated-for in updated treatment plans. Daily re-
planning offers superior dose precision over the current standard of practice, in which a 
single treatment plan, created from pre-treatment imaging, is re-delivered over the course 
of many weeks. Unfortunately, treatment planning is traditionally a time-consuming 
procedure, typically requiring between one and two weeks to complete, depending on the 
complexity of the treatment. The primary challenge of OART is to condense the entire 
treatment planning process into a less than 20 minute timeframe, while the patient waits in 
the treatment position. Although MR-guidance is a key factor to implementing OART, the 
presence of the strong magnetic field, and resulting EREs affecting the dose, necessitating 
the use of much slower Monte Carlo dose calculation methods, imposing further strain to the 
reduction of treatment planning duration. 
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3 PARALLEL BEAMLET DOSE CALCULATION VIA 
BEAMLET CONTEXTS IN A DISTRIBUTED MULTI‐
GPU FRAMEWORK34 
3.1 Introduction 
Modern radiation treatment planning is powered by inverse optimization algorithms 
that require causal information connecting the plan delivery parameters to the resultant 
patient dose distribution. This information is encapsulated in a dose influence matrix, 
consisting of the dose of individual beamlets, which are the smallest deliverable unit whose 
geometry is typically determined by the multi-leaf collimator width. Monte Carlo (stochastic) 
simulation is regarded as the gold standard for dosimetric accuracy but remains 
impractically slow for very large scale (VLS) optimization problems. On the other hand, 
deterministic approaches provide a faster approximation by convolving reusable dose 
spread kernels over analytically computed TERMA fields on each unique patient geometry. 
The popularity of deterministic convolution superposition (C/S) solvers such as collapsed-
cone convolution superposition (CCCS)17,47 and analytical anisotropic algorithm (AAA)19 
have enabled acceptably accurate clinical dose calculation that can typically be performed 
with an order of magnitude reduction in time required for general purpose (Geant4) and 
even special purpose (VMC++) Monte Carlo methods in some circumstances24. 
In practice, the dose influence matrix calculation speed is generally acceptable with 
modern computers for IMRT plans involving only a few pre-determined beams. For arc 
optimizations and TomoTherapy, two orders of magnitude greater number of beamlets are 
needed to construct the matrix. Owing to the evidence that non-coplanar beam orientations 
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and automatic selection of beams and arc trajectories has been shown to produce improved 
plan quality40,48–54, there is great research interest in automatic orientation selection from a 
much larger set of beam candidates by learning-based55 and dose-driven approaches38,56–58. 
One such method, non-coplanar IMRT with beam orientation optimization38, selects beams 
from several hundred candidates, escalating the requirement for dose calculation 
proportionally. More recently, dynamic collimator rotation41 and non-coplanar VMAT40 have 
been developed for further improved dosimetry and delivery efficiency, pushing the 
requirement of beamlet dose for optimization to be ~1000 times greater than that of fixed 
beam IMRT plans to account for the additional degrees of freedom. Dose calculation for the 
increasing number of beamlets can be a slow process by clinical standards, particularly when 
higher dosimetric accuracy is desired. There has not yet been an improvement to dose 
calculation processes using collapsed cone beamlet dose generation that would make these 
VLS treatment planning methods clinically tractable, despite the clear dosimetric benefits 
granted for heterogeneous geometries. The purpose of this work is to improve the dose 
calculation speed for these VLS planning methods so that standard clinical implementation 
may be achieved. 
Since deterministic dose calculation is an embarrassingly parallel computational 
problem, graphics processing units (GPUs) with a large number of computational cores have 
found widespread success in accelerating dose calculation for treatment plan optimization 
and validation purposes. Chen et al. employed efficient GPU memory coalescing and 
analytical dose spread kernels to achieve 1000-3000x speedup over the CPU-CCCS 
implementation for TomoTherapy dose calculation59,60. Neylon et al. further optimized 
memory access speeds during GPU-CCCS convolution by first transforming voxelized TERMA 
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to a basis aligned with each collapsed-cone direction and subsequently carrying out efficient 
parallelized line convolutions, demonstrating further acceleration over the CPU method61. 
Tian et al. developed a GPU Monte Carlo dose calculator (goMC) based on the OpenCL GPU 
computing framework to enable widespread adoption of Monte Carlo simulation across all 
popular GPU hardware architectures62. Ziegenhein et al. delocalized the dose calculation 
process with an integrated cloud-based Monte Carlo framework that allows dynamic scaling 
of computational resources as needed to reduce workstation cost and complexity, improving 
the expectation for performance scaling with additional hardware on short-lived simulations 
where gains were previously pervasive63. Park et al. performed beamlet-based dose 
convolution with adaptive finite-sized pencil beam kernels to reduce the number of beamlets 
required to model arbitrary field shapes and accelerate volumetric dose verification for the 
optimized fluence maps64. Cho et al. validated the use of a GPU-accelerated convolution-
superposition method for kilovoltage dose calculation in small animal irradiation research65.  
The foundation for our approach is the nonvoxel-based (NVB) GPU dose calculation 
algorithm of Neylon et al.61 which optimizes previous GPU-based CCCS methods66–68 by 
employing efficient GPU memory handling practices. The NVB algorithm is an improvement 
over these algorithms in that it reduces latency in device memory access by successive 
transformation of the CT density data to align it with each collapsed-cone ray enabling 
efficient line-convolution. Like the NVB approach of Neylon et al., we treat the convolution 
operation on a continuous domain with interpolation during dose kernel sampling and dose 
spread. Unlike the NVBB approach of Lu69, which treats TERMA and dose calculation in a 
continuous domain without discretely modeling beamlets, we maintain the standard voxel-
based beamlet-superposition (VBS) representation in the output of our algorithm such that 
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we follow the path of pre-calculating discrete, beamlet-specific dose distributions for use 
during plan optimization. We make this choice primarily to maintain compatibility with the 
variety of beamlet-based planning techniques.  
Our contributions are two-fold. First, we propose a novel modification to the existing GPU 
implementation of full beam deterministic dose calculation, enabling efficient low-level 
parallel computation of beamlet-specific dose using a beamlet-context transformation. 
Second, we implement our beamlet-based GPU dose calculation algorithm in a scalable 
distributed framework supporting flexible high-level multi-GPU acceleration. Our 
framework greatly improves the efficiency of the VBS method for use in VLS optimization 
problems such as dose driven automatic IMRT beam orientation38 and VMAT trajectory 
optimization40,41, 4π48, and TomoTherapy70 treatment planning. In this study we introduce 
the framework for our method, provide some dosimetric characterization for standalone 
beamlets and their composition as a broad beam, measure its computational performance, 
and discuss the scalability across networked computational nodes. We also discuss the 
computational efficiencies enabled by our proposed method and how it could potentially 
benefit VLS optimization problems but recognize that classification of dosimetric accuracy 
in clinical treatment planning settings is a more involved matter and leave such investigation 
to future work. 
3.2 Materials and Methods 
In this section, we describe our novel beamlet context approach for efficient beamlet-
based dose calculation on a GPU. Next, we show that our method may be further parallelized 
in a scalable manner across a network of multi-GPU compute nodes. Finally, we describe the 
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experiments designed to quantify our framework’s dosimetric accuracy against Monte Carlo 
and CPU-CCCS reference doses and computational speed in comparison to an existing GPU 
model-based method. 
3.2.1 Nonvoxel-Based Dose Calculation 
3.2.1.1 Beamlet-based Dose by Intra-beam Parallelization 
Dividing the dose calculation problem into per-beam tasks is a trivial matter. While 
others have chosen to further separate the problem into per-beamlet tasks, we instead chose 
to calculate dose for these beamlets simultaneously. Our algorithm processes each beam as 
a unit, concurrently producing independent dose distributions for each of the beam’s active 
beamlets before writing them to file and continuing with the next beam. This innovation is 
the key to achieving an efficient and scalable algorithm that minimizes GPU execution and 
memory management overhead. Details of the low-level parallelization are explained in the 
subsequent sections. 
3.2.1.1.1 TERMA Calculation 
Dose calculation for each beam begins by first generating a binary fluence map where 
active beamlets are assigned a unit fluence. Active beamlets are defined by projecting the 
target onto the fluence plane at the isocenter (Figure 3-1a) and detecting intersections with 
the target volume along each of 9 rays configured for each beamlet as shown in Figure 3-1b. 
If any sample ray intersects any part of the target volume, the beamlet is considered active 
and its dose will be calculated. This approach is used frequently for beamlet dose calculation 
and effectively minimizes the computational complexity of the full problem without 
sacrificing plan quality. 
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Figure 3-1. (a) Intersection map for one beam orientation and target volume definition. 
Purple-colored cells have no target intersection and are excluded from beamlet-dose 
calculation, yellow: full intersection, others: partial intersection. (b) Super-sampling ray 
layout for testing beamlet-target intersection. (c) cross-section of TERMA calculation sub-
voxel arrangement for super-sampled averaging (2x and 3x options shown for one voxel). 
The binary fluence map is used in calculating the TERMA by means of a path-length 
tracing procedure47 that implements a modified version of Siddon's71 algorithm better suited 
to the GPU. For every voxel, 𝑖, in the volume, a ray is traced between the source position and 
the voxel’s center, along which, the radiological path length is accumulated, according to 
Equation 3-1, for a line segment of variable length 𝑙𝑗  through each voxel j∈ ℛ𝑖  of density 𝜌𝑗  . 
𝑑𝑖 =∑ 𝑙𝑗𝜌𝑗
𝑗∈ℛ𝑖
 
Equation 3-1 
To maximize calculation speed, dose is calculated assuming a constant polyenergetic 
beam spectrum. Since beam hardening effects change the true beam spectrum within an 
attenuating medium, an auxiliary value, 𝑇𝑖
∗, is calculated for each voxel, 𝑖, and used instead 
of the actual TERMA, 𝑇𝑖 , during dose convolution. Equation 3-2 shows the expression for 𝑇𝑖
∗, 
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with respect to 𝑇𝑖 at voxel 𝑖, including corrections for beam hardening and the inverse square 
effect of diverging beams. 
𝑇𝑖
∗ = (
𝐷𝑠,𝑎
2
𝐷𝑠,𝑖
2 )𝐻𝑖𝑇𝑖 
where 
𝑇𝑖 =∑ Ψ𝐸 (
𝜇𝐸
𝜌
) 𝑒
−(
𝜇𝐸
𝜌 )𝑑𝑖
𝐸
 
Equation 3-2 
𝐷𝑠,𝑎  is the distance from the source to the rotational axis (isocenter), and 𝐷𝑠𝑣  is the 
distance from the source to voxel 𝑖, in the direction of the beam’s central axis. Through the 
beamlet context extraction process, described in the following section, kernel tilting is 
implicit and a corrective term (𝐷𝑠,𝑎
2 𝐷𝑠,𝑖
2⁄ ) for the inverse-square effects of a diverging beam 
is applied directly to each 𝑇𝑖. 𝐻𝑖 is a voxel depth- and tissue density-dependent factor based 
on an effective x-ray attenuation coefficient, which corrects for beam hardening effects. It is 
interpolated from a table of pre-computed values specific to each beam spectrum and 
material. For this study, a single fluence-attenuation-table (FAT) was calculated and used for 
a 6MV bremsstrahlung x-ray spectrum in water.  Because the utilized dose kernels are 
precomputed in homogeneous water, the energy-dependent mass attenuation ( 𝜇𝐸/𝜌 ) 
coefficients are constant and equal to those of water. Thus, to correct for material 
inhomogeneity, a standard C/S technique72 is used, whereby the kernel is instead warped 
according to the material dependent radiologic pathlength, 𝑑𝑖 for each voxel (expressed in 
Equation 3-1). 
Anti-aliasing via uniform super-sampled averaging is employed during TERMA 
calculation with negligible cost to address aliasing (stair-stepping) otherwise observed 
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along the beam and beamlet edges. Each voxel is divided into a set of 𝑘3 sub-voxels, for the 
user-selected integer super-sampling level, 𝑘 , as depicted by Figure 3-1c. The ray-based 
path-length and TERMA calculations are performed for each sub-voxel, and the voxel’s 
TERMA is assigned to the average of their values. The entire low-level process is presented 
for one compute node in Figure 3-2a, including the GPU modules and post-processing tasks. 
The distributed workflow in Figure 3-2b is explained further in section 3.2.1.2. 
 
Figure 3-2. (a) Beamlet dose calculation workflow. A single worker node processes beams in 
parallel across its resident GPU devices. Beamlet processing is further parallelized on a GPU 
using beamlet contexts. (b) Distributed computing framework. The manager node prepares 
independent task lists for each worker node to process in parallel and receives the results for 
delivery to the requestor. 
3.2.1.1.2 Beamlet Context Extraction 
The classical implementation of beamlet-based dose calculation treats each beamlet 
separately and performs dose calculation for each, one-by-one. While a functional solution, 
this approach results in a linear scaling of calculation times with the total number of 
beamlets as in Equation 3-3. 
Calculation Time ∝∑ 𝑛𝑏
𝐵
𝑏=1
     for  [
𝐵: # of beams
𝑛𝑏: # beamlets in beam 𝑏
 
Equation 3-3 
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Our method instead reduces the time scaling factor to 𝐵 by calculating individual dose 
for all beamlets in a beam at once. During dose calculation for one beamlet on the GPU, 3D 
dose spread is applied for every voxel in parallel. This approach to parallelizing the problem 
is sub-optimal because the random-access latency of globally stored data during convolution 
is high and the speed of the algorithm suffers. Trying to directly implement the NVB 
algorithm with support for beamlet-based dose calculation presents other difficulties such 
as introducing dose assignment race conditions66 and inflating the memory footprint beyond 
feasibility with beamlet specific book-keeping. Attempting to store dose directly as a sparse 
array on the GPU to overcome memory consumption limits also introduces deleterious race 
conditions and memory access latencies since constant speed random-access of memory is 
no longer possible. 
To circumvent these problems, we recognize that the dose resulting from common 
clinical x-ray spectra is spread locally around an interaction point with compact spatial 
support. For the purposes of radiation beam selection and fluence map optimization, a close 
approximation of the dose can be obtained by limiting the calculation of dose spread to the 
immediate neighborhood of each beamlet. This approximation known, as kernel or dose 
truncation, has been used previously for dose kernel generation73 and simultaneous Monte 
Carlo beamlet dose simulation74 to accelerate dose calculation. Utilizing this approximation, 
we construct a composite array of independent beamlet contexts (hereafter referred to as the 
context array; depicted in Figure 3-3) that each contain only the density and TERMA data 
necessary for performing the CCCS convolution operations within its beamlet’s confined 
surroundings. The long axis of each context is aligned in parallel to the long axis of its beamlet 
(called beamlets-eye-view; BEV) such that a minimum distance from any voxel of the 
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beamlet to the boundaries of the context is enforced by the selected context radius, as 
described by Figure 3-4. Aligning the contextual data in this way also implicitly corrects for 
beam divergence effects that would otherwise require costly kernel tilting to be individually 
applied for every beamlet. Since the contexts are independent and self-containing, their 
arrangement in the construction of the context array is unremarkable and therefore flexible. 
To construct each beamlet’s context, we directly sample density from the global coordinate 
system, while mapping each voxel in the context to its corresponding global coordinate and 
directly calculating TERMA at this location using the method described in section 3.2.1.1.1. 
We ensure that only TERMA attributable to a context’s beamlet is included in the context by 
projecting onto the fluence plane and testing membership in the fluence element 
corresponding to that beamlet using the procedure outlined previously.  
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Figure 3-3. (a) Visualization of the beamlet context array for a single beam including 
contextual densities and beamlet-specific dose after calculation. (b) Beamlet context cross 
sections for various context radii with dose overlaid. (c) Convolution-ray-aligned context 
array (cross-section) for various kernel rays. Grey area is allocated once and reused for all 
beams. White subregions are allotted for kernel-ray-specific convolutions geometry. Black 
cells indicate unused space after packing beamlet contexts into the array. Convolution 
direction is into page. 
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Figure 3-4. Construction of one beamlet context with implicit kernel tilting. Blue region 
indicates the volume of non-zero TERMA for a single beamlet. The distance between the blue 
rings in the transverse view is representative of the context radius setting. The union of red 
and gold boxes represents the volume in which dose is computed. 
3.2.1.1.3 Nonvoxel-Based Transformation 
We combined our novel context transformation with the NVB algorithm61 to calculate 
beamlet-specific dose in parallel. To understand the motivation behind the NVB algorithm, 
we briefly describe the structure of the Monte Carlo point spread kernels; a complete 
presentation can be found in the literature17,20,47. The kernels used in our approach contain 
coefficients calculated in a polar system of homogeneous water with 24 radial and 48 angular 
points. By collapsing the full cartesian sampling space into a set of radially divergent cones, 
the dose distribution may be closely approximated at a much lower computational cost. 
During convolution, the dose is only calculated for voxels intersecting the central axes of 
these cones rather than for a radial ray terminating at each of the original sampling points 
on the dose grid. This is the defining distinction of CCCS over more precise C/S algorithms.  
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One simple way to structure the CCCS algorithm on the CPU is to iterate over the volume, 
stopping at each voxel to spread dose to surrounding voxels before moving to the next 
iterate. In GPU computing, memory read and write latencies usually present the greatest 
barrier to an efficient implementation. A direct translation of the CPU-based approach to GPU 
leads to substantial memory latency and introduces race conditions that force expensive 
synchronization of GPU threads to obtain correct results. Same as the NVB algorithm, we 
combat these issues by resampling (rotating) the context array along each kernel ray in turn, 
placing TERMA and density data into a new coordinate system referred to as the rays-eye-
view (REV). We use tri-linear interpolation to cast the original density and TERMA data into 
the context-based REV and back into the global coordinate system. As such, each mapping is 
affine and performed on a continuous spatial domain. Furthermore, each mapping is 
invertible to the extent of the data retained after truncation by the selected context radius. 
After transformation, each row of the contextual data is arranged as a contiguous block of 
memory permitting its efficient access by coalesced GPU memory transactions during 
convolution. In doing so, we reduce the memory access overhead and amplify the benefits of 
GPU parallelization. 
As there are many rays along which the dose will be spread during convolution with the 
dose kernel, the array of Figure 3-3a is reconstructed in the REV specific to each convolution 
ray prior to dose calculation. The resulting dose is successively transformed into a fixed 
common orientation, which aligns every context central axis in parallel with the data column 
direction, for accumulation until dose for all rays has been calculated. To efficiently obtain 
beamlet-specific dose for every one of a beam’s active beamlets in parallel, we maintain three 
arrays in the current REV coordinate system to store the contextual density, TERMA, and 
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resulting dose. A fourth array is kept in the common orientation for accumulation of dose 
from each REV. GPU memory requirements for the context-based method are primarily 
determined by the sizes of these four arrays which change based on a number of user-
controlled and geometry specific factors such as the number of active beamlets in each beam, 
and various quality settings (voxel size and context radius among others). To maximize 
computational efficiency, we pre-determine these memory requirements for every beam 
before initializing the memory allocations. This allows us to instead allocate a single set of 
memory for these four arrays with sufficient size to fit all scenarios rather than repeatedly 
allocating and deallocating smaller memory segments and suffering from the significant 
overhead that such CUDA API operations impose on overall runtime. The single allocation is 
represented by a grey box in Figure 3-3c, and convolution along each kernel ray uses its own 
subset of this memory (white box), dependent upon the rotated geometry of the context 
array. To provide flexibility of our method to GPU hardware with lower available memory, 
we further implement optional beamlet batching which divides the complete context array 
for a beam into two or more sub-arrays to process successively. We allow explicit control 
over the number of batches for all beams when desired, and otherwise, dynamically detect 
when GPU memory restrictions necessitate batching for each beam on an individual basis. 
3.2.1.1.4 Dose Ray Convolution 
For each instance of the ray-specific REV-aligned context array, line convolution is 
carried out over the rows of the REV-aligned context array for every voxel along the kernel 
ray. By design, the density and TERMA accessed by the voxels in each row are restricted to 
the values coincident with each ray. This data is cached into shared memory for fast repeated 
access by neighboring voxels, offering hundreds of times less latency than global memory on 
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average75. GPU thread race conditions are avoided by treating the CCCS operations from the 
"dose deposition point of view"47,66, enabling each thread to assign to its own voxel-specific 
memory address without conflicting with the data write operations of other threads. Each 
convolution is performed on a nonvoxel basis with linear interpolation using the cumulative 
kernel (CK) technique developed by Lu76 and summarized by Neylon61. To obtain the full 
dose distribution for each beamlet, this line convolution procedure is performed along each 
kernel ray, and the dose from each is transformed into a common orientation and 
accumulated. 
3.2.1.1.5 Beamlet Context Dose Extraction 
The dense dose distribution attributed to each context’s beamlet is stored in the context 
array in the common orientation. The selection of context radius determines the physical 
spatial extent to which the scattered dose is recorded. To represent this dose distribution in 
the original coordinate system, a beamlet specific affine transformation is applied to each 
context and the dose data is converted to a sparse representation in a two-column 
coordinate list (COO) format. One column contains the linearized volume index of each non-
zero element, while the second column contains the corresponding value (dose). A threshold 
may be configured at this stage to exclude elements of negligible magnitude to further reduce 
storage size and improve data storage speeds. After conversion to the COO format, the dose 
data is written in a widely supported and flexible binary format (HDF5) to disk to be recalled 
and used during treatment planning. 
3.2.1.2 Distributed Parallelization 
Additional high-level parallelization of the algorithm is achieved by embedding our 
context-based approach into a distributed multi-GPU framework. We harness the trivial 
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separability of per-beam processing to build a network of computational workers, each of 
which may provide one or more GPUs. The division of labor among the worker nodes is 
simple and flexible with respect to the number available and is based on the computation of 
each beam as a standalone labor unit. 
The beamlet dose calculation task is first executed on a managing node whose job is to 
prepare the static data (CT and configuration) and assign per-beam processing tasks to the 
workers. The manager node considers the availability of worker nodes and the number of 
GPUs provided before transferring the requisite data and task assignments to each. Upon 
receipt, the worker further assigns per-beam tasks to its resident GPUs which each take 
responsibility for one beam at a time and run concurrently. Processing on each GPU proceeds 
as described in section 3.2.1.1. The resulting beamlet dose data is immediately transferred 
over the network to the managing node for inclusion in the user-facing HDF5 file. The 
process flow detailing the distributed parallelization structure is described in Figure 3-2b. 
3.2.2 Measuring Computational Efficiency 
To quantify the performance of our context-based GPU-CCCS method for beamlet dose 
calculation, we measured and compared its computational efficiency against an existing 
GPU-CCCS implementation48 that calculates beamlet dose in sequence. Beamlet doses for two 
representative 4π plans were calculated with isotropic 2mm voxel sizes and the average 
calculation times for each beam were recorded. Each plan was composed of the same 1,162 
beam specifications distributed spherically around prostate and lung PTV definitions in two 
distinct CT geometries. The total number of beamlets for each plan was dependent upon the 
PTV shapes; 434,670, and 302,643 beamlets were calculated in total by each method in the 
prostate and lung targets respectively. Both our context-based GPU-CCCS and the existing 
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beamlet-sequential GPU-CCCS implementations shared CCCS quality settings that were set 
to match one another, such as the number of convolution rays (𝑁𝜃 × 𝑁𝜙). The additional 
beamlet context radius parameter of our method was tested at 1, 2, and 3cm to demonstrate 
the flexibility provided in balancing speed and accuracy. The per-beamlet calculation 
bounding box margins for the sequential GPU-CCCS method were matched to the context 
radius to control for the effects of calculation over reduced volumes of different sizes when 
measuring the performance. 𝑁𝜃  and 𝑁𝜙  were set to 8×8 and 16×16 for both methods to 
quantify computational efficiency in these two common configurations. We also provide 
results for our method in distributed configurations with 1, 2, and 3 networked worker 
nodes, each employing two GPUs for a total workforce of 2, 4, and 6 GPUs respectively. To 
compare peak GPU memory usage for each of the sequential and context-based GPU-CCCS 
methods, 20 random non-coplanar beam orientations were selected (10 from each of the 
prostate and lung CT geometries), and doses for rectangular fields composed of various 
quantities of 5×5mm beamlets were calculated. Isotropic 2mm voxels and 16×16 
convolution rays were configured throughout testing, and the context radius of the context-
based GPU-CCCS method was additionally varied between 0.3cm and 3cm. For each set of 
quality parameters, the same 20 beam orientations were processed in a single program 
execution and the peak GPU memory usage was recorded. 
3.2.3 Measuring Dosimetric Accuracy 
Accuracy comparisons between the beamlet-sequential GPU-CCCS algorithm48 and the 
NVB algorithm61 of which our method is an extension have already been analyzed and will 
not be repeated here. Instead, we provide an investigation of the accuracy of our context-
based method against Monte Carlo and a reference CPU-CCCS implementation in two 
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phantom geometries: one homogeneous water, and one heterogeneous stack of slabs, each 
detailed in Figure 3-5. Monte Carlo dose was obtained using Geant4 for a continuous 
emission spectrum of a diverging square monoenergetic photon beam, fit to the discrete 
spectrum used by CCCS. Monoenergetic dose kernels used in our context-based GPU-CCCS 
and the CPU-CCCS methods were previously synthesized17 using an EGSnrc code, and the 
same emission spectrum was used to construct a polyenergetic kernel for dose convolution. 
Doses for 5mm, 1cm, and 2cm wide beamlets were calculated. A voxel size of 1x1x1mm3 was 
selected to compare the dose profiles of all beamlets more accurately. For the context-based 
GPU-CCCS method, the context radius was fixed at 4cm. Central beamlet-axis percent depth 
dose (PDD) and lateral beamlet line profile at a depth of 10cm were visualized along with 
the error of our method from the CPU-CCCS and Monte Carlo results.  
 
Figure 3-5. Cross sections of phantom geometries with beam entering from the top; used to 
assess dosimetric accuracy. Materials and densities are provided. 
To support the assumption that beamlet dose can be well estimated by calculating only 
within a limited interaction context, we varied the context radius parameter between 0.1cm 
and 8cm for each of the three previously tested beamlet widths in the water phantom. From 
these experiments, the lateral beamlet profile at 10cm depth is included with the maximum 
39 
volumetric error for each pairing of beamlet width and context radius compared to dose for 
the same beamlet without using the context-based approximation by the beamlet-sequential 
GPU-CCCS method. 
We also constructed a 5×5cm2 broad beam by addition of context-based dose for 100 
adjacent 5×5mm2 beamlets in the water phantom and compared the broad beam lateral dose 
profile to that of a broad beam composed of beamlet dose calculated without use of the 
context-based approximation. Lateral dose profiles were analyzed at depths of 5cm, 10cm, 
and 15cm and the broad beam error associated with the context-based method was also 
reported. 
Finally, the ability of our approach to scale to increased hardware availability and 
reducing the overall calculation time was investigated through timing experiments on 
multiple nodes and code execution profiling. Execution profile data were averaged across 
three independent application executions with 50 randomly selected 4π beams in each. All 
experiments were performed using NVIDIA GeForce TITAN X graphics cards from the 
Maxwell architecture. GPU programming was done using CUDA v9.0. For single-node 
performance evaluation, one node acted as both the manager and worker, employing an intel 
Xeon E5-2670 CPU with 8 physical cores and a base clock speed of 2.6GHz. For multi-node 
evaluation, workers having either an Intel i7-5820K CPU with 6 physical cores and a 3.3GHz 
clock, or an Intel i7-7700K CPU with 4 physical cores and a 4.2GHz clock were used. All data 
transfers between host and device memory were facilitated over 16-lane (x16) PCIe 3.0 
interfaces. 
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3.3 Results 
In Table 3-1 we present the time required by each algorithm to calculate beamlet dose 
for one beam averaged over the set of 4π treatment beams48. Our framework is implemented 
such that we measured calculation time for a single GPU as well as in various distributed 
multi-GPU configurations, emulating simple deployment scenarios. Figure 3-6 shows how 
the performance of our approach scales in single-node and multi-node configurations as a 
function of the number of GPUs utilized. The colored dashed lines show the scaling 
performance in the single-node configuration, where GPUs are simply added to an existing 
compute node. Colored solid lines indicate performance gains when GPUs on additional 
worker nodes are introduced instead. 
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Table 3-1. Per-beam Calculation Times (average, in seconds) 
Treatment Site Prostate Lung 
𝑵𝜽 ×𝑵𝝓       𝟖 × 𝟖 𝟏𝟔 × 𝟏𝟔 𝟖 × 𝟖 𝟏𝟔 × 𝟏𝟔 
Single Node     
Sequential (1 GPU) 226.4 818.4 47.0 155.2 
Context (1 GPU, 0.3cm context) 2.362 2.799 1.686 2.016 
                (1 GPU, 1cm) 3.066 6.322 2.312 4.958 
                (1 GPU, 2cm) 5.159 13.731 3.385 9.142 
                (1 GPU, 3cm) 9.119 29.765 5.343 17.137 
     
Multi-node     
Context (1x 2 GPU, 2cm context) 3.130 11.977 1.964 7.466 
                (2x 2 GPU, 2cm) 1.643 6.288 1.031 3.919 
                (3x 2 GPU, 2cm) 1.127 4.312 0.707 2.688 
Average per-beam dose calculation times (in seconds) for various hardware configurations, 
and quality settings 
 
Figure 3-6. Performance for single-node and multi-node scaling strategies. For multi-node 
measurements, each node was configured with 2 GPUs. The dotted black line indicates 
theoretical linear scaling in multi-node setups. 
A decomposition of our algorithm into the fractions of time spent on each sub-procedure 
is given in Figure 3-7 for various quality settings on a single node. Additional profiling results 
for use of various GPU counts on a single node are given in Figure 3-8. 
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Figure 3-7. Fractional execution time spent in each sub-procedure on one computational node 
with 4 threaded post-processing “SparseAgents”. Only time spent on the main processing 
thread is represented. 
 
Figure 3-8. Fractional execution time for 1cm context radius with a variable number of 
background post-processing (dose sparsification) threads. Only time spent on the main 
processing thread is represented. 
The memory usage recorded for both the sequential and context-based GPU-CCCS 
methods are listed in Table 3-2. Figure 3-9 shows these results in graphical form. 
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Table 3-2. Peak Memory Usage For GPU-based CCCS Methods (in Megabytes) 
 
Context-Based GPU-CCCS 
(by context radius) 
 Sequential  
GPU-CCCS 
 0.3cm 1cm 2cm 3cm  
50 beamlets 200.07 244.23 528.34 1053.16  959.03 
100 beamlets 188.12 382.64 980.64 2136.38  973.84 
150 beamlets 255.09 618.59 1774.54 4014.71  985.25 
200 beamlets 323.60 864.74 2643.31 5634.15  1001.78 
GPU memory usage for sequential and context-based GPU-CCCS methods for 2x2x2mm3 voxels 
and 16x16 convolution rays. 
 
 
Figure 3-9. Peak memory usage for various beamlet counts and context radii. 
Figure 3-10 and Figure 3-11 give the PDD along the beamlet’s central axis, the centered 
lateral line profile at 10cm depth, and the error for each result compared with the CPU-CCCS 
and Monte Carlo methods. Results of our approach are given in color for each beamlet size 
in both the water and stacked slab phantoms. Monte Carlo outcomes are presented in grey, 
and CPU-CCCS dose is given as a dotted curve. Normalized error between our method and 
each of the Monte Carlo and CPU-CCCS methods are additionally given. 
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Figure 3-10. Single-beamlet depth dose and lateral profiles in the water phantom for 
increasing beamlet widths. Error is calculated between our context-based GPU-CCCS method 
and each of CPU-CCCS and Monte Carlo. 
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Figure 3-11. Single-beamlet depth dose and lateral profiles in the stack of slabs phantom for 
increasing beamlet widths. Error is calculated between our context-based GPU-CCCS method 
and each of CPU-CCCS and Monte Carlo. 
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The maximum error of the context-based compared to non-context-based beamlet dose 
resulting from various selections of context radius for the water phantom is given in Figure 
3-12 with the resulting lateral line profile at 10cm depth. Absolute errors are expressed as 
percentages of the maximum reference volume dose calculated without the context-based 
approximation. 
 
Figure 3-12. Central lateral line profile in the water phantom at 10cm depth for various 
beamlet widths and context radii pairs (top). Maximum errors (%) between non-context-
based (infinite radius) and context-based dose profiles are provided (bottom). The dose is 
normalized to the maximum dose in the volume. Y-axis range is limited to better depict low 
dose beamlet penumbra region where context-based approximation is active. 
3.4 Discussion 
3.4.1 Performance 
The performance improvements offered by our context-based method over the beamlet-
sequential GPU-CCCS method are evident from Table 3-1. When a 2cm context radius is used 
on a single GPU for both methods, our approach offers 44-60x speedup and 14-17x speedup 
for the prostate and lung plans respectively. These results demonstrate a clear efficiency 
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advantage of our context-based processing. Even for a larger context radius of 3cm, ours 
demonstrates 25-28x and 9x speedups over the beamlet-sequential GPU-CCCS method 
configured with its beamlet dose calculation margin matching the context radius; 
demonstrating pure acceleration without truncation-induced loss of dose fidelity. Analysis 
of the error reported in Figure 3-12 shows that less than 1% beamlet-specific PDD error 
could be achieved in the water phantom for the 5x5mm2 beamlet width by setting the context 
radius to just 3mm. Targeting this beamlet dose error of less than 1% we additionally timed 
our approach on the 4π dose calculation task using the reduced 3mm context radius. In this 
test, our method demonstrated even greater single GPU acceleration rates of 95-292x and 
28-77x compared to the beamlet-sequential GPU-CCCS baseline for the prostate and lung 
plans respectively.  
With its simplicity in scaling, our approach was also configured for multi-node 
calculation. When distributed across three workers employing two GPUs each, for a total of 
only six GPUs, we measured acceleration factors of 190-200x and 58-66x for the prostate 
and lung plans respectively, using a 2cm context radius. Applying the results of the single 
GPU experiments, we expect even greater accelerations for the dosimetrically similar 3mm 
and 1cm context radii. Figure 3-6 presents complete evidence of our framework’s scalability, 
reaching nearly linear efficiency gains in the number of GPUs used in a multi-node 
configuration. Network latency didn’t contribute significant overhead in our testing. 
However, we believe multi-node scaling performance can be further enhanced by utilizing 
dedicated 10 Gigabit inter-node connections to increase the network communication 
bandwidth over the 1 Gigabit connections used during testing but will leave such 
confirmation for future work. 
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Looking more closely at Figure 3-6, we observed that the single node performance gains 
quickly plateaued beyond use of three GPUs for the lung target. A performance bound isn’t 
observed for the prostate, since we did not have the resources to test the single-node 
configuration with more than four local GPUs. We hypothesized that as the number of GPUs 
increased on a node, the beamlet dose of multiple beams is computed much more quickly 
than it can be transferred to the host, converted to a sparse format, and stored to the hard 
drive (collectively referred to as post-processing). By limiting the number of GPUs on each 
device, and instead increasing the number of computational nodes, we spread the GPU 
computational resources across more CPUs and output disks, and better balance the 
computational speed with the post-processing speeds. We tested this hypothesis for both 
treatment sites by distributing GPUs over more nodes and found that the multi-node 
configuration reduces the effects of the bottleneck, overcoming the undesired plateau of 
performance scaling seen in Figure 3-6. 
To confirm our hypothesis moreover, we analyzed our algorithm using standard code-
profiling techniques. Figure 3-7 indicates that the only sub-procedures with strongly-
dependent runtime contention as the context radius and quality of the dose increase are 
Context Construction and Dose Convolution, both implemented on GPU. This is expected since 
these functions are dependent on the size of the context array which is directly affected by 
manipulation of the context radius. Unlike the former two GPU operations, which are 
executed once for each convolution ray, the Extract Context Dose operation is executed once 
for every beamlet to transform each set of computed beamlet dose data from the context 
array (in the arbitrary common orientation, introduced in section 3.2.1.1.3) to the original 
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coordinate system. This is a simple transformation and is made efficient by coalesced GPU 
memory access from the context array.  
Undesirable, however, is the observation that copying the dose data from the GPU to the 
host memory (GPU-CPU Data Transfer) follows a weakly scaling trend, indicating that even 
as the quality of the dose (context radius) is reduced, the total computation time approaches 
a lower bound, in part determined by the memory transfer bandwidth between the host and 
GPU device. The other, more dominant factor determining the efficiency bound is the speed 
of post-processing (dose sparsification and storage). Since these tasks place post-processing 
requests in a fixed-size queue and are handled by a team of SparseAgents in separate CPU 
threads, we only see these operations contribute to the total runtime (CPU Functions) when 
the GPU outpaces the CPU. When this occurs, GPU computation is paused to limit the host 
memory usage while the post-processing queue is sufficiently depleted. The combination of 
the Wait for Available SparseAgent and Copy Data to SparseAgent operations indicate the 
amount of time that the main processing thread must wait while the occupancy of the post-
processing queue is reduced. This type of delay is most pronounced when many GPUs are 
available on each node. This limit is demonstrated in Figure 3-8 where we see that nearly 
every GPU operation shortens in aggregate as more GPUs are added to a node, while the 
inline post-processing operations initially shorten as more threaded SparseAgents are 
provisioned but quickly exhibit diminishing returns; further supporting our hypothesis that 
the single-node algorithm performance is bounded by the post-processing time consumed 
on each worker.  This time is in turn dominated by CPU core availability, as well as hard drive 
write and network transfer speeds, that can potentially be alleviated by increasing network 
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transfer bandwidth and distributing GPU resources over more computational nodes, as 
suggested. 
Using the memory usage results, reported in Table 3-2 and Figure 3-9, we show that the 
primary factors determining the GPU memory usage of the context-based GPU-CCCS method 
are the number of beamlets in each beam, and the selected context radius, in addition to the 
general considerations such as voxel size and patient size (determining the beamlet length) 
common to all CCCS methods. We observed that for some combinations of beamlet count and 
context radius, the peak GPU memory usage was similar. Further investigation of these cases 
confirms our intuition that for each, a context array (Figure 3-3a) of similar size and shape 
was constructed. As expected, the peak memory usage of the sequential GPU-CCCS algorithm 
shows no impactful dependence on the number of beamlets in each beam, due to the 
sequential calculation of beamlet dose inherent to the technique. A weak correlation was 
observed but is insignificant and likely caused by changes in bookkeeping and the geometry 
of the calculated beamlets as the field size changes and intersects with different volumes of 
the CT. As described in section 3.2.1.1.3, we’ve developed the context-based GPU-CCCS 
method with optional dynamic beamlet batching to alleviate high memory usage concerns 
for cases such as that with 200 beamlets and 3cm contexts, showing peak usage of 5.6GB. 
With this feature, we hope to increase compatibility with budget-friendly GPUs providing 
less total memory. 
3.4.2 Accuracy 
Like the NVB algorithm on which we’ve based the core of our algorithm, calculated dose 
closely agrees with the CPU-CCCS calculated dose in the water phantom (Figure 3-10), with 
maximum single-beamlet PDD errors of 2% beyond the high dose gradient region found in 
51 
the first few millimeters of the phantoms. Single-beamlet lateral dose profile errors in the 
water phantom are greatest at the beamlet edges where high dose gradients are again 
observed. Inspection of the beamlet profile errors in Figure 3-10 indicate that the context-
based method consistently displays smaller error in these regions when compared to Monte 
Carlo dose than when compared to CPU-CCCS dose, likely due to the use of TERMA super-
sampling that has been employed in the context-based method to this effect. Errors in profile 
dose in the primary portion of the beamlets are below 2% on average between context-based 
and Monte Carlo methods for all beamlets sizes. This small error results from slight depth-
dependent difference seen in the beamlet PDDs in the water phantom geometry (Figure 
3-10), likely caused by the use of a continuous beam spectrum in Monte Carlo simulation 
rather than a discrete spectrum as in CCCS.  
Single-beamlet dosimetric errors observed in the slab phantom (Figure 3-11) are slightly 
larger overall than those found in the water phantom. The greatest deviations of the context-
based method from Monte Carlo beamlet dose occurs after interfaces between media of 
substantially different densities (particularly at depths of 32, 64, and 160mm), an effect 
attributable to the well-known shortcomings of the heterogeneity correction used in the 
CCCS method that have already been independently investigated28,77,78. Closer agreement of 
our context-based GPU-CCCS method with the reference CPU-CCCS implementation at these 
interfaces support this explanation. Despite these inherent shortcomings in the CCCS 
algorithm, the context-based method shows average single-beamlet PDD errors of 
magnitude less than 1.35% and 2.35% for all beamlet sizes in the water and slab phantoms, 
respectively. 
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The dose truncation effects of our context-based approach are evident in Figure 3-12 
where its resemblance to cylindrical kernel truncation73 in the lateral direction is clear. In 
line with our expectation, the maximum single-beamlet profile error decreases quickly as 
the context radius is increased. The rate of decrease in the error is smaller as the beamlet 
size is made larger, because more dose is physically scattered outside of the primary beam, 
as observed by the longer tails of the 2cm wide beamlet compared to the 0.5cm beamlet. The 
profile error for the 5x5cm2 wide broad beam, composed as a sum of 100 5x5mm2 wide 
beamlets, presented in Figure 3-13, shows that full beam dose profile errors below 5%, and 
10% can be expected for context radii above 2cm and 1cm, respectively. The nature of the 
context-based method makes it difficult to directly truncate the polyenergetic dose kernel 
and renormalize its remaining weights to sum to 1, and thus, energy is not strictly conserved 
in the current implementation. We instead recommend the intuitive use of a small context 
radius when the beam candidate pool is large, such as in early stage of automatic beam 
orientation optimization which considers over 1,000 beams. Approximate dose is often 
sufficient for ruling out trivially unsuitable beam orientations and the context radius can be 
increased to recompute more accurate beamlet dose once the beam candidate pool has been 
reduced. 
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Figure 3-13. Lateral line profile in the water phantom at various depths for a 5×5cm2 broad 
beam calculated as the sum of 5×5mm2 beamlets for various context radii at three depths. 
Dose for “infinite” radius was computed without context-based approximation. 
Our current implementation relies on the user-defined context radius which corresponds 
to a physical path length from the edge of a beamlet. We have also considered dynamically 
setting the context radius of each beamlet in response to local density patterns. By so doing, 
beamlets in homogeneous high-density environments would be assigned low radii to match 
the short radiological path lengths, while those in low density or heterogeneous 
environments would be assigned higher radii. This adaptive approach would allow more 
optimal allocation of computational resources to beamlets where distant dose scatter is 
expected; this work, however, has been left for future investigation. 
3.5 Applications 
Our accelerated context-based GPU-CCCS dose calculation method has been used to 
enable effective planning of several new treatment paradigms for which the VLS beamlet 
dose calculation requirements have traditionally been restricting. Here we discuss a 
54 
selection of applications for which our accelerated GPU-CCCS method has supplied the 
computational impetus. 
3.5.1 A sparse orthogonal collimator for small animal intensity‐
modulated radiation therapy79,80 
3.5.1.1 Background 
Advances in the precision of therapeutic radiation delivery, such as IMRT, have greatly 
increased the dose conformity and normal tissue sparing, but the clinical benefits from 
improved dose distributions alone will likely plateau because the limits in radiation 
tolerance for normal tissues may halt further improvement in the treatment outcome for 
radioresistant tumors81. The next major advancements in radiation therapy are believed to 
come from developments in knowledge of the underlying radiobiology of healthy and 
cancerous tissues. In order to better understand which novel treatment techniques will 
translate to improved clinical outcomes in humans, preclinical validation is required.  
To meet this need, preclinical research using small animal models, particularly mouse 
models, have been used extensively as inexpensive and versatile tools for gaining valuable 
insight into cancer growth dynamics and the biological effects of radiation82,83. However, due 
to the inconsistencies and inadequacies of irradiation techniques used in several preclinical 
radiotherapy studies, the use of animal models has shown limited benefit84–90. Recent 
development of dedicated image-guided small animal irradiators, like the X-RAD smART 
system from Precision X-ray Inc., has greatly expanded the potential for preclinical 
radiotherapy research91. To ensure better translation of preclinical research to clinical 
application, the modern dose modulation techniques used for IMRT must be emulated in the 
preclinical setting. For this purpose, we’ve introduce a new method to delivery small animal 
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IMRT using the previously described sparse orthogonal collimator (SOC)92 that can be more 
easily miniaturized for the small animal scale, and a planning system that supports the use 
of this simple, yet powerful, dose modulation device.  
3.5.1.2 Methods 
This novel small animal IMRT method is based on the idea that by adapting the previously 
formulated direct aperture optimization (DAO) method36, effective IMRT treatments using 
only rectangular apertures can be delivered. For treatment planning of SOC-based IMRT we 
have formulated the Rectangular Aperture Optimization problem (described previously92) 
as 
minimize
𝛼
 
1
2
‖𝑊(𝐴𝑅𝛼 − 𝑑0)‖2
2 + 𝜆‖𝛼‖1
subject to 𝛼 ≥ 0
 
Equation 3-4 
The optimization variable, 𝛼 ∈ ℝ𝑃, is a vector encoding the optimal fluence for each of 
the P pre-defined apertures, 𝑅 ∈ {0,1}𝑁𝑥𝑃is the binary matrix that maps the per-aperture 
fluence values from 𝛼 into N per-beamlet fluence values(𝑓 ∈ ℝ𝑁 as presented in Equation 
2-4), 𝐴 ∈ ℝ𝑀𝑥𝑁 is the standard beamlet dose matrix mapping beamlet fluence to a 3D dose 
distribution for the plan, and 𝑊 ∈ ℝ𝑀𝑥𝑀 is a diagonal weighting matrix defining the relative 
importance of meeting the ideal dose (𝑑0) for every voxel or anatomical structure (set of 
voxels). The L1 regularization term imposing sparsity on 𝛼 is designed to limit the number 
of apertures and make the plan’s delivery more efficient. A complete description of the 
optimization procedure is provided by Nguyen et al92. 
To ensure accurate planning and radiation delivery, a series of beam commissioning 
measurements were performed on the X-RAD smART irradiator. Analysis of these 
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measurements revealed imperfections in the spectral quality and uniformity of the 
generated X-ray beam. Consequently, in addition to X-ray fluence, the dose delivered by each 
aperture becomes a function of its size and position in the field of view. The additional 
dependence required consideration of dose deposition for multiple beam energy spectra, 
characteristic of each aperture size, greatly inflating the dose calculation requirements for 
this application. To enable an accurate solution to the problem in Equation 3-4, compatible 
with the system imperfections, our multi-GPU CCCS dose calculation method was employed 
to calculate the planning dose data for every beamlet using five different beam energy 
spectra; introducing a five-fold increase to the standard dose calculation requirement of 
IMRT. The five energy spectra were defined by estimating the distribution of X-ray energy 
for five square apertures with side lengths equal to 1, 3, 5, 10, and 20 mm.  
Equation 3-4 was solved five times in parallel, once for each energy spectrum, to arrive 
at five versions of 𝛼, each containing a distribution of aperture sizes. Automatic selection of 
between 5 and 20 beams from a candidate pool of 180 coplanar beams was performed using 
the 4π beam orientation optimization method, which has been previously published 
extensively48,49,99,50,54,93–98. For each subject, the total number of beamlets requiring dose 
calculation was as many as 1.5 million, which is over 2 orders of magnitude more than is 
typically required for a clinical IMRT plan with 7 manually selected beams. For each plan, the 
apertures were grouped according to their aperture size. Then, each plan’s deliverable dose 
was calculated by summing the dose for all groups, each recalculated using the energy 
spectrum for the square aperture most closely matched in size to the apertures of the group. 
From the accurate deliverable dose, the apertures selected in the first optimization were held 
fixed, and their fluences were re-optimized. This important fine-tuning step enhances the 
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plan quality from the first optimization, where all apertures assumed a single beam energy 
spectrum rather than the one most appropriate for their size. 
Three dosimetric experiments were conducted in which SOC plans for a C-shaped 
concave target, a mouse whole liver, and a highly modulated “Audrey” plan, were created 
using the procedure described in the previous section. Each plan was delivered to pre-
calibrated, dose-sensitive Gafchromic EBT3 film using the X-RAD smART system. 
Radiologically analogous phantoms (Figure 3-14) were 3D-printed using a tissue-equivalent 
flexible material with integrated slots for placement of the EBT3 film. The measured 2D dose 
distributions were compared with the calculated deliverable dose distributions obtained 
from our multi-GPU CCCS dose calculation method on the basis of dose statistics (minimum, 
maximum, and mean) and using a gamma analysis100 to produce the percentage of voxels 
with a sufficiently high gamma index to be considered as passing according to the 4%/0.3mm 
gamma criteria. 
 
Figure 3-14. (Left) Mouse phantom modeled from mouse CT data and 3D-printed with a 
flexible, tissue-equivalent material and a mid-coronal split for film measurement. Phantom is 
shown on the previously mentioned rotating couch mount. (Right) 3D-printed block phantom 
for axial dose measurements. Figure reproduced from Woods et al. (2019)80. 
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3.5.1.3 Results and Discussion 
Figure 3-15 shows the calculated (left) and measured (center) dose distributions for the 
C-shaped target plan. The gamma analysis with 4%/0.3 mm criteria revealed a pass rate of 
~95% for pixels within the target structure, and 85% for the entire field shown. The 
maximum and mean absolute pixelwise dose differences were 4.12 and 0.59 Gy, respectively 
(Table 3-3), and the measured dose to the target had slightly higher maximum (15.8% of the 
prescription dose), mean (7.0%), and minimum (13.5%) doses. The 50% isodose lines are 
shown in Figure 3-15 (right), demonstrating excellent overall agreement between the 
calculated and measured dose distributions. 
 
Figure 3-15. (Left) Calculated dose distribution of the C-shaped target plan perpendicular to 
the gantry rotation axis. (Center) Measured film dose distribution from the center of the solid 
water phantom for the C target plan delivered with the SOC. Both plans are shown with the 
same color scale, in units of Gy. (Right) A comparison of the calculated (yellow) and measured 
(blue) 50% isodose lines, with overlapping regions shown in red. Figure reproduced from 
Woods et al. (2019)80. 
Table 3-3. Comparisons between the measured and intended dose distributions for the C-
shaped target plan and the mouse phantom whole liver plan. Table reproduced from Woods 
et al. (2019)80. 
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Dose Statistics  
(measured – calculated) 
Pixelwise Dose Comparison 
Plan Structure Max Mean Min Max Diff Mean Diff 
Gamma 
Pass Rate 
C Target C 
+1.58 
(15.8%) 
+0.70 
(7.0%) 
+1.35 
(13.5%) 
4.12 
(41.2%) 
0.59 
(5.91%) 
94.9% 
Mouse 
Liver 
Liver 
+1.30 
(13.0%) 
-1.02 
(10.2%) 
+1.10 
(11.0%) 
3.50 
(35.0%) 
1.19 
(11.9%) 
98.2% 
Kidneys 
+0.43 
(4.3%) 
+0.24 
(2.4%) 
+0.11 
(1.1%) 
0.43 
(4.3%) 
0.24 
(2.4%) 
100% 
*Max, mean, and min dose differences written as [Gy (% prescription dose)]; Max and Mean 
Diff are absolute pixelwise dose differences; gamma analysis was performed with 4%/0.3 mm 
criteria for dose/distance 
The results of the mouse phantom liver test plan are shown in Figure 3-16, with the liver 
and kidney dose comparisons given in Table 3-3. The maximum measured liver dose was 
13.0% higher than the calculated dose, the mean was 10.2% lower, and the minimum was 
11.0% higher. As evident in the film dose distribution and isodose comparison shown in 
Figure 3-16 (C) and (D), the lower left portion of the liver was cut off due to slight phantom 
misalignment. The affected pixels were omitted from the liver dose analysis. For the 
unaffected pixels within the liver, the gamma analysis showed a high pass rate of 98.2%. The 
measured SOC plan was able to significantly spare the dose to the kidneys, with maximum 
and mean doses of 0.43 and 0.24 Gy, respectively. These are only 4.3% and 2.4% higher than 
the calculated doses, and therefore all pixel-wise differences were within 5% of the intended 
dose. 
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Figure 3-16. (A) Mid-coronal view of the calculated dose for the mouse phantom whole liver 
plan (units of Gy). (B) The 5 optimal coplanar beam angles selected with the 4π algorithm. (C) 
Measured film dose from the mouse phantom, treated with the whole liver plan, at the plane 
shown in A (units of Gy). (D) A comparison of the calculated (yellow) and measured (blue) 
60% isodose lines, with overlapping regions shown in red. *Target structure was rotated to 
account for slight phantom misalignment, which also resulted in the truncated lower left 
portion of the target. Figure reproduced from Woods et al. (2019)80. 
The calculated and measured doses for the 2-dimensional Audrey test plan are shown in 
Figure 3-17. The maximum and minimum measured film doses were both 1.1 Gy higher than 
the calculated dose distribution (12.2% of the maximum intended dose), with a mean 
pixelwise absolute dose difference of 1.6 Gy. Although this plan shows some discrepancies 
in absolute dose prediction for very small apertures sizes, the sources of which are discussed 
in Woods et al. (2019)79, the spatial distribution is extremely similar to the calculated plan, 
validating the overall accuracy of the SOC hardware and control software. 
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Figure 3-17. (Left) Calculated Audrey test plan with 4 dose levels and an average aperture size 
of 2.35 mm. (Right) Measured dose distribution of the Audrey plan delivered with the SOC. 
Both plans are shown with the same color scale, in units of Gy. Figure reproduced from Woods 
et al. (2019)80. 
All three SOC plans showed measured dose deposition that was consistent with the 
expectation, calculated by our GPU-CCCS method. Furthermore, the entire SOC treatment 
planning process can currently be completed for one subject in only a few hours, despite the 
substantial increase in required dose calculation data (approximately 128 times more) 
compared with traditional IMRT planning. 
3.5.2 A novel optimization framework for VMAT with dynamic gantry 
couch rotation40 
3.5.2.1 Background 
Optimization of plans for Volumetric Modulated Arc Therapy (VMAT) is more challenging 
than for static beam IMRT due to its large problem size and more complex delivery 
constraints. Typically, 180 or more beams are included in VMAT delivery compared with 
fewer than ten beams used in a typical IMRT plan. More importantly, the gantry rotation and 
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leaf motion are coupled: for efficient VMAT delivery, the MLC leaf movements between 
adjacent gantry angles cannot exceed the product of the maximal leaf speed and the gantry 
travel time, which is short to maintain smooth and efficient gantry rotation. The heuristic 
progressive sampling optimization (PSO) method for VMAT101 successfully addressed the 
mechanical constraint problem and kept the computational complexity manageable but fails 
to provide a globally optimal plans and greatly relies on interactive input from an 
experienced dosimetrist.  
To overcome these limitations, a level-set-based direct aperture optimization for 
coplanar-arc VMAT was developed37, which solves the entire arc optimization problem in 
full angular resolution. This non-progressive sampling approach was shown to generate a 
single arc coplanar VMAT that outperformed progressive sampling VMAT using two arcs 
with the same number of control points in each arc. Recent 4π IMRT research, which enables 
automatic noncoplanar beam orientation optimization (BOO) from a large candidate pool 
has demonstrated significant dosimetric gains compared to the VMAT plans48,93,102. 
In this study, we propose a novel optimization framework, termed 4πVMAT, that 
simultaneously solves the complete non-coplanar VMAT trajectory optimization and DAO 
problems for VMAT, while ensuring deliverability by avoiding couch-gantry-patient collision 
and enforcing mechanical constraints of MLC leaf motion and gantry rotation. 
3.5.2.2 Methods 
Our optimization framework takes an alternating approach between solving simpler 
subproblems for DAO, BOO, and beam trajectory selection (BTS). An objective was 
formulated to jointly solve the DAO and BOO sub-problems using the Fast Iterative 
Shrinkage-Thresholding Algorithm (FISTA)46 for the current solution to the BTS sub-
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problem. The BTS sub-problem was modelled after a traveling salesman problem in which 
the goal is to discover the most efficient path through all the nodes of a graph based on the 
edge costs connecting them. Here the nodes were defined by the complete set of possible 4π 
beam from a discretized grid over couch and gantry angles. The edge costs were defined as 
positive infinity between any two nodes for which the motion connecting them during 
delivery was impossible. The BTS problem was solved using Dijkstra’s algorithm, which is a 
dynamic programming method that can be used to identify the shortest path between two 
nodes of a weighted graph. For patient safety and comfort, the edge costs were designed to 
enforce a constant couch rotation direction within each arc while the gantry was permitted 
to rotate dynamically. 
By alternating between solutions to the DAO&BOO and BTS sub-problems, a deliverable 
and dosimetrically desirable 4πVMAT plan can be discovered with the properties that the 
fluence map for each aperture is constant, only a single aperture is selected for each control 
point, the total number of control points is low, and the apertures are smoothly varying 
between adjacent control points. Optimization of a 4πVMAT plan considers 2400 candidate 
beams, for which beamlet dose must be calculated. Using a standard 20×20cm2 field of view 
for each beam with 5×5mm2 beamlets, the total dose calculation requirement is as high as 
more than 3.8 million individual beamlet doses imposing a significant strain on existing dose 
calculation approaches which have been developed for the clinically standard purpose of 
IMRT planning with typically fewer than 10 manually selected beams (up to only 16,000 
beamlets) or coplanar VMAT with a substantially lower number of control points in total; 
typically only 80 per arc, and up to two or three arcs. Our GPU-CCCS beamlet dose calculation 
method was utilized to efficiently calculate the dose data required by the 4πVMAT 
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optimization. Plans for 4πVMAT and more traditional, manually selected coplanar arc 
therapy (termed 2πVMAT) were created for three glioblastoma multiforme, three lung 
cancer, and three prostate cancer patients. The 4πVMAT and 2πVMAT plans were compared 
on the basis of their plan quality (PTV and OAR statistics) and delivery efficiency.  
3.5.2.3 Results and Conclusions 
The 4πVMAT plans demonstrate their flexibility to distribute the dose in any non-
colliding direction within the 4π spherical beam space, depending on the benefits to OAR 
sparing and PTV coverage, whereas 2πVMAT plans are restricted to dosimetrically inferior 
coplanar delivery that demands planning experience from the human dosimetrist to achieve 
acceptable but still inferior dosimetry compared with the 4πVMAT plans. The 4πVMAT plans 
were able to markedly reduce dose to OARs while achieving comparable or better PTV 
statistics across all patients, especially for the dose limiting organs, such as the brainstem in 
the GBM #2 and GBM #3, the proximal bronchus in all three LNG patients, the major vessels 
in LNG #2, and LNG #3, and the seminal vesicle and the rectum in all PRT patients. 
Optimization of the 4πVMAT plans is still somewhat slow due to the complexity in tuning 
hyperparameters compounded with the heavy computation costs at each iteration. Planning 
took between 1 hour for the GBM cases to 9 hours for the lung and prostate cases. Delivery 
of 4πVMAT plans was between 3 and 5 minutes for all plans which is comparable to the 
conventional 2 or 3 arc 2πVMAT plans. 
Optimization of 4πVMAT plans in its current form is effective at improving plan quality 
while maintaining efficient delivery, but in its current form is computationally intensive due 
to the optimization problem size and alternating optimization between DAO&BOO and BTS. 
Some avenues for further acceleration of the optimization exist such as GPU implementation 
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of expensive matrix multiplications in each FISTA iteration and progressive up-sampling of 
the dose data in later iterations of optimization. Nonetheless, the conventionally time-
consuming precursor to optimization, beamlet dose calculation, was significantly 
accelerated by our GPU-CCCS approach to span the gap between the typical dose calculation 
workload of coplanar arc VMAT and our new dosimetrically superior paradigm of 4πVMAT. 
3.5.3 Single-Arc VMAT optimization for Dual-Layer MLC44 
3.5.3.1 Background 
Recently, significant advances have been made in VMAT planning algorithms37,40,41 but 
the focus has only been placed on single-layer multi-leaf collimators (SLMLC) thus far. Dual-
layer multi-leaf collimators (DLMLC)103–105 with “stacked and staggered” leaves offer an 
alternative with two distinct advantages: substantially reduced inter-leaf leakage, and 
simpler and more cost-effective construction. Two new commercial medical linacs, Halcyon 
(Varian Medical Systems) and MRIdian (ViewRay) have adopted DLMLC. In this work, we 
have developed a VMAT optimization method that specifically manages the dosimetric 
effects of coupling between the two MLC layers by simultaneously solving for both MLC 
layers and the entire arc in full angular resolution, using an alternating optimization 
approach that has been investigated in previous studies37,40,41. 
3.5.3.2 Methods 
In this study, we focus on optimization of plans for delivery of coplanar VMAT arcs 
specifically on the Halcyon, without loss of generality. In the Halcyon, the two layers of the 
DLMLC are stacked and staggered by half of the leaf width to provide more sophisticated 
modulation than SLMLC with the same leaf width. Figure 3-18a shows the DLMLC with 
stacked 10 mm wide leaves (DLMLC-10mm) compared to the SLMLC with 5mm leaves in 
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Figure 3-18b, and the SLMLC with 10mm leaves and either 10mm or 5mm longitudinal leaf 
positioning step size in Figure 3-18c-d (SLMLC-10mm and SLMLC-10mm-5mm). The 
DLMLC-10mm affords greater dose modulation capability than the SLMLC-10mm 
configuration, since one layer of the DLMLC-10mm can be left open to emulate the leaf 
positioning of the SLMLC-10mm, or both layers can be used for more complex collimation. 
But the coupling effect of the dual MLC layers expectedly adds complexity to the optimization 
of identical structures compared to the SLMLC.  
 
Figure 3-18. Demonstration of (A) DLMLC with 10mm leaf width (DLMLC-10mm), (B) SLMLC 
with 5mm leaf width (SLMLC-5mm), (C) SLMLC with 10mm leaf width (SLMLC-10mm), (D) 
SLMLC with 10mm leaf width and 5mm leaf step size (SLMLC-10mm-5mm). The grids on (C) 
and (D) represent the achievable beamlets. Figure reproduced from Lyu et al. (2019)44. 
To solve the DLMLC optimization challenge, a direct aperture optimization problem is 
formulated44 to simultaneously optimize dose fidelity, and VMAT deliverability feasibility 
and efficiency. The optimization problem is solved via an alternating optimization approach 
by fixing all but one optimization variable in each module, and iteratively updating each 
variable conditioned on the current states of the rest. To enable efficient planning, our GPU-
CCCS beamlet dose calculation method was used. For each of four plans, one glioblastoma 
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multiforme, one lung cancer, one prostate cancer, and one rectal cancer, 180 beams were 
selected with 2-degree spacing to form a full VMAT arc. The field of view for each DLMLC-
10mm beam was divided into a 40×40 grid of 5×5 mm2 beamlets, producing a total dose 
calculation requirement for approximately 290,000 beamlets, representing a 2.25-fold 
increase in dose calculation over conventional VMAT with only 80 control points-per-arc in 
general and a SLMLC with 5×5 mm2. More substantially, however, is the 9-fold increase in 
beamlet dose requirement for DLMLC-10mm compared to conventional SLMLC-10mm with 
the same MLC construction cost. To compare plans based on MLC modulation capability 
alone, all plans were optimized with the same 180 control points. 
3.5.3.3 Results and Conclusions 
The proposed DLMLC VMAT optimization algorithm optimizes all beams simultaneously and 
produces 5mm-resolution apertures that are deliverable using DLMLC-10 mm. Figure 3-19 
shows the DVHs of the DLMLC-10mm plan and the SLMLC plans for all patients. The DLMLC-
10mm and the SLMLC-5mm plans are nearly indistinguishable. With the same leaf width, the 
DLMLC-10mm plan OAR sparing is superior to both the SLMLC-10mm-5mm and the SLMLC-
10mm plans for all patients. Considering the Halcyon’s maximum MLC leave movement 
speed of 50 mm/s, the estimated delivery time is 36 s for the GBM and lung cases, and 90 
seconds for the prostate case. 
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Figure 3-19. DVH for (A) the GBM case, (B) the LNG case, (C) the PRT case, and (D) the REC-SIB 
case. The solid lines are for the DLMLC plan, and the dotted lines are for SLMLC plans. D95 is 
normalized to the prescription dose. Figure reproduced from Lyu et al. (2019)44. 
In this study we have shown that DLMLC VMAT can be optimized to outperform 
conventional SLMLC-10mm plans achieve comparable plan quality with SLMLC-5mm VMAT. 
DLMLC-10mm takes advantage of the faster gantry rotation and leaf speed of new ring 
gantry linacs such as the Halcyon to enable more efficient plan delivery than coplanar VMAT 
on a C-arm linac. Compared with the previously reported Halcyon VMAT plans106,107, which 
need more arcs to achieve comparable dosimetry to a VMAT plan on traditional TrueBeam 
C-arm linac, the proposed method clearly elevated the performance of single-arc DLMLC 
VMAT to be equal to SLMLC with higher resolution leaves. The full angular resolution DLMLC 
problem can be solved in 5 minutes for the GBM and lung cases, and 20 minutes for the 
prostate case. With the accelerated dose calculation enabled by our GPU-CCCS algorithm, 
online adaptive DLMLC planning steps into the realm of clinical feasibility with an 
approximate total planning time of less than 30 minutes even with relatively low investment 
in distributed computational hardware. 
3.5.4 Many Isocenter Optimization for Robotic Radiotherapy43  
3.5.4.1 Background 
The development of 4π non-coplanar radiotherapy48,93 has fostered significant 
improvements to the achievable dosimetric plan quality of IMRT treatment. However, the 
potential for patient-gantry collision in widely used C-arm linacs limits the optimization and 
treatment outcome while requiring complex coordinated gantry and couch motion. By 
replacing the C-arm linac with a robotic arm delivery platform, the number of collision-free 
beam angles is increased, and the beam-to-beam motion is simplified, but the need for a more 
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compact X-ray emission head introduces a new conflict between field size and MLC 
modulation resolution. This study investigates the dosimetry and delivery efficiency of 
treatment to multiple isocenters to achieve simultaneously high dose modulation resolution 
and large tumor coverage. 
3.5.4.2 Methods 
We investigate a novel method of multiple-isocenter non-coplanar IMRT planning with 
simultaneous fluence map optimization and beam selection. Without loss of generality, we 
adopt the geometry of the new robotic linac that is currently under development at Celestial 
Oncology (Figure 3-20). 
 
Figure 3-20. (A) Demonstration of the robotic arm platform, (B) an isocentric SID-100 beam 
that covers the entire target, (C) beams of different isocenters are required to efficiently cover 
the entire target. Figure reproduced from Lyu et al. (2020)43. 
The selection of source-to-isocenter distance (SID) affects both the dose modulation 
resolution and beam field of view (FOV). To study the effects of SID on plan quality and 
delivery efficiency, two SIDs are considered: 100 cm and 50 cm. At SID-100, the projected 
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MLC leaf width at the isocenter is 1 cm, and the FOV is 20×20 cm2. Likewise, at SID-50 the 
projected MLC leaf width is 0.5 cm, and the FOV is 10×10 cm2. Ideally, the projected MLC leaf 
width should be minimized for maximized dose delivery precision, however for Head and 
Neck (H&N) cancer with a PTV up to 20 cm in length, the target cannot be fully covered by 
the reduced FOV of the the SID-50 beam. In order to facilitate use of the SID-50 beams with 
their enhanced dose modulation resolution, we employed a heuristic isocenter selection 
approach. The PTV is first tightly bounded by a cuboid aligned to the scanner’s coordinate 
axes, which is then evenly divided into [𝑁𝑥, 𝑁𝑦, 𝑁𝑧] cells. For each cell, an isocenter position 
is calculated as the center of mass (CoM) of the enclosed partial PTV. The set of isocenters 
selected using this method guarantees sufficient coverage of the PTV but does not 
necessarily guarantee that all isocenters will be used in the final plan; it may be the case that 
fewer isocenters are necessary for achievement of optimal dosimetry. 
An optimization problem was formulated43 to simultaneously solve for the optimal set of 
beams and their X-ray fluences from the candidate pool of all considered beams for all 
isocenters. Plan optimization for 10 H&N patients was performed according to the 
parameters determining the overall dose calculation and optimization problem sizes in 
Table 3-4. 
Table 3-4. Number of feasible beams, prescription doses and PTV volumes for all patients. 
Table reproduced from Lyu et al. (2020)43. 
Patient 
PTV 
volume 
(cm3) 
Bounding Box 
(cm) 
Isocenter 
# 
Feasible beam 
# 
Sampled beam 
# 
x y z 
SID- 
100 
SID- 
50 
SID- 
100 
SID- 
50 
SID- 
100 
SID- 
50 
H&N #1 610.5 9.3 14.3 15.8 1 4 776 2785 1162 4648 
H&N #2 724.6 10.8 16.0 18.3 1 8 826 1440 1162 2320 
H&N #3 947.0 10.0 17.0 22.3 2 12 1579 2117 2324 3480 
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To limit the computational costs, for plans with fewer than or equal to four isocenters, 
1,162 beams were uniformly sampled in the 4π spherical space around each isocenter with 
6° of separation. For other cases with more isocenters, 290 beams were instead uniformly 
sampled with 12° of separation for each isocenter. The average number feasible beams, after 
excluding beams with the potential for collision with the patient, was 887 (69% of sampled 
beams) for SID-100 plans, and 1,754 (60% of sampled) for SID-50 plans. To estimate delivery 
efficiency of all plans, a traveling salesman problem was formulated108 and solved, producing 
an optimized ordering of beams that reduced the amount of linac head travel and MLC leaf 
motion. 
3.5.4.3 Results and Conclusions 
Overall, the SID-50 plans resulted in higher dose fidelity values compared with the SID-
100 plans using the same number of beams, showing superior dosimetric plan quality to the 
SID-100 plans. As the number of delivered beams increased, the SID-50 plan quality 
improved more quickly than the SID-100 plans. When 20 or more beams are used, SID-50 
shows clear dosimetric advantage over SID-100 (Figure 3-21) for all cases. 
H&N #4 785.0 10.3 15.5 19.0 1 8 891 1452 1162 2320 
H&N #5 686.4 10.5 14.5 18.3 1 8 824 1422 1162 2320 
H&N #6 787.0 10.5 16.5 17.5 1 8 842 1443 1162 2320 
H&N #7 352.7 8.5 8.5 18.5 1 2 758 1315 1162 2324 
H&N #8 555.7 9.8 13.3 14.8 1 4 906 2904 1162 4648 
H&N #9 271.3 8.8 6.8 17.0 1 2 781 1385 1162 2324 
H&N #10 620.5 10.3 15.0 14.0 1 8 685 1278 1162 2320 
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Figure 3-21. Final objective value vs the number of beams. The plot with shaded error bar 
shows a summary of all patients. Each patient plot is titled with the patient number, the 
number of isocenters for the SID-50 plan, and the number of isocenters for the SID-100 plan. 
For example, the first patient plot is entitled: ‘#1: 4(50), 1(100)’, showing that the patient #1 
has four isocenters for the SID-50 plan, and one isocenter for the SID-100 plan. Figure 
reproduced from Lyu et al. (2020)43. 
The average delivery time for a 20-beam plan, delivered over 30 fractions, in each case 
was 12 minutes for SID-50 and 7 minutes for SID-100, with the longer time being attributed 
to longer MLC travel time, which is the most time consuming aspect among monitor unit 
(MU) delivery time, linac head travel time, and itself. For a hypo-fractionated delivery over 
5 fractions, the higher MU delivery requirement of each fraction tilts the balance of fractional 
delivery time from an MLC travel time-heavy to an MU delivery-heavy time requirement, 
which equalizes the average overall delivery for SID-50 (15 minutes) and SID-100 (14 
minutes). Due to the inverse square effect of radiation delivery, the SID-50 plans with one-
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half the x-ray propagation distance to the target feature a factor of four higher dose rate than 
the SID-100 plans, allowing for nearly comparable delivery times when MU delivery is the 
most time consuming component of delivery. 
Treatment planning with integrated optimization of multi-isocentric delivery offers 
dosimetrically comparable outcomes compared to single-isocentric delivery using a C-arm 
linac and standard SID of 100 cm. The ability of our many-isocenter approach to produce 
effective plans in applications with reduced FOV, such as for novel compact X-ray emission 
heads and robotic-arm positioning, expands the possibility for efficient and less restrictive 
traversal of the entire 4π spherical beam space, affording greater dosimetric gains over the 
more restrictive C-arm gantry geometry. Using our efficient GPU-CCCS beamlet dose 
calculation framework, we can efficiently meet the 2-fold greater planning dose data 
requirements over the traditional C-arm 4π treatment planning problem. With an average 
planning time of 25 minutes for 15-beam plans, and 22 minutes for 50-beam plans, our 
approach can be implemented in a clinically feasible timeframe of less than one day in total. 
3.6 Conclusions 
We developed and implemented a highly efficient GPU-CCCS algorithm for computing 
beamlet dose with customizable fidelity using an intuitive context radius setting for high 
beam counts in complex static-beam and dynamic arc IMRT planning problems. We’ve 
demonstrated that the use of our novel parallel beamlet context-based technique 
substantially outperforms the naive approach of computing beamlet dose in sequence as is 
done by existing CCCS algorithms in terms of efficiency, while maintaining similar levels of 
dosimetric accuracy. Additionally, we embedded this approach in a scalable high-
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performance computing architecture that allows the number of independent computing 
nodes, and the number of GPUs employed by each to be adapted to match the resources and 
demands of the user. Finally, several applications of novel treatment paradigms, enabled by 
the efficiency of our GPU-CCCS algorithm for beamlet dose calculation, were presented. 
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4 A HIGH‐PERFORMANCE DISTRIBUTED 
FRAMEWORK FOR LARGE‐SCALE MONTE CARLO 
DOSE CALCULATION 
4.1 Introduction 
For the purposes of radiation treatment planning in the common clinical setting of CT-
guided megavoltage X-ray therapy, Analytical approaches to dose calculation, such as AAA, 
CCCS, and more recent iterative linearized Boltzmann transport equation solvers strike an 
effective balance between dosimetric accuracy and calculation speed. For the emerging 
paradigms of MR-guided X-ray, proton, and heavy ion therapies, however, more complex 
particle physics results in non-trivial deviations in dose deposition from those for which 
efficient analytical dose calculation algorithms have historically been developed and 
validated. For MR-guided X-ray RT, complications to the dose deposition physics arise in the 
form of electron return effects (EREs) induced by the Lorentz force experienced by electrons 
traveling through a strong magnetic field, such as the 1.5 tesla field used widely for 
diagnostic MRI and in modern MRgRT linacs like Elekta’s Unity MR-guided linear 
accelerator5. In proton and heavy ion therapies, these complications exist due to the 
geometry dependent ranges of heavy particles that exhibit highly non-linear dose deposition 
rates with increasing depth of tissue penetration. 
To address the need for accurate dose calculation methods in each of these applications, 
established Monte Carlo (MC) methods, in which dose depositing particles are individually 
simulated through a prescribed patient according to a set of physical interaction 
probabilities, have been thrust to the forefront of clinical practice. While MC-based dose 
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calculation techniques have proved versatile in handling the complexities involved with 
these new treatment modalities, they remain substantially slow in comparison to the 
analytical methods employed in CT-guided X-ray therapy. MC’s inefficiency is marked by the 
necessity for simulating hundreds of thousands of primary particles into complex voxelized 
geometries derived from a patient’s pre-treatment or daily CT image acquisition. 
Complementary practices for improving treatment effectiveness such as beam orientation 
optimization and volumetric modulated arc therapy with automatic trajectory optimization 
create a demand for many orders of magnitude more dose calculation data prior to treatment 
planning. Another complementary paradigm, online adaptive radiotherapy (OART), has a 
patient’s treatment re-planned from daily image acquisitions to adapt the deliverable dose 
to changes in patient anatomy and alignment in the radiation delivery equipment for 
enhanced dosimetric accuracy. In OART, the patient remains in the treatment position while 
re-planning is performed, thus placing challenging limitations on the amount of time 
available for dose calculation to be less than 5 minutes. For maximum improvement to 
treatment efficacy, these methods are ideally combined into a single standard of practice, a 
goal that remains infeasible in large part due to the insufficient dose calculation speeds of 
MC. 
In order to enable further research of emerging paradigms in radiation therapy and new 
approaches for the acceleration of MC dose calculation, a stop-gap strategy for performing 
rapid and large-scale MC dose calculation with existing technologies was necessary. To meet 
this need, distributed computing concepts were applied to create an integrated framework 
for the automated and parallelized calculation of dose data with the ability to scale to an 
arbitrarily large pool of computational resources.  
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4.2 Implementation 
Our platform for rapid MC dose calculation is implemented using an efficient 
combination of the Python, C++, and CUDA programming languages where most appropriate. 
Python provides the integration layer tying together the many components of a treatment 
planning system, such as the data organization, network communication, input/output, and 
user interface modules. Python is also used for implementing RT-domain-specific algorithms 
where absolute raw computational efficiency is of little concern, but flexibility and ease of 
implementation is necessary to maintain the platform’s customizability to new applications. 
Generation of particle source parameters for use by the MC simulation engine is one example 
of this focus on customization over performance; this task is accomplished by only a few 
affine transformations and implementation in a compiled language closer to the 
computational hardware would introduce too much inflexibility with negligible gain in 
overall performance of the system. For other tasks where computational efficiency is 
important, such as in raytracing to define each of the dose calculation tasks, C++ and CUDA 
are selected for implementation; this performant code is then integrated into the high-level 
Python code when appropriate. 
4.2.1 Distributed Computation Model 
Enabling the capacity for unfettered parallelization of the expensive MC dose calculation 
tasks is our model for distributed processing. From a high-level, we organize a set of always-
running compute nodes (computers) around a central managing node. Every compute node 
runs a persistent process that listens on a TCP/IP network socket and waits for instructions, 
at which time it begins a locally multi-threaded MC simulation for one beamlet. The contents 
of the instruction payload that the compute node receives include all necessary input 
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configuration for executing the beamlet dose simulation task using one of the pre-
established MC simulation engines. Based on the usage requirements of the dose calculation 
framework, these engine choices may include one for traditional X-Ray dose calculation, one 
for the more specialized considerations of heavy ion dose calculation, and another still for 
brachytherapy dose calculation. Our framework currently supports the Geant4 MC engine 
for general purpose dose calculation of nearly every clinically useful particle type, and 
support for a special purpose proton MC engine is currently in progress. The resulting dose 
data, runtime log, and anything else requested by the user of the engine are packaged into a 
response payload that is sent back to the requesting node over the same network socket 
session. After confirming that the response payload has been successfully delivered, all 
traces of the previous simulation are cleaned up and the next simulation task in the compute 
node’s local task queue is processed. Safe handling of exceptions and reporting of runtime 
errors to the requesting node ensure that this persistent process can remain running for 
months without loss of service. 
Compute nodes are only designed to continuously process well-defined MC simulation 
tasks with no regard for the broader details of treatment planning. The managing node, 
conversely, handles all other aspects of dose calculation for treatment planning, such as 
determination of all simulation task configurations, queuing of tasks in prioritized order, 
scheduling of tasks on remote compute nodes, and efficient organization of the thousands to 
hundreds of thousands of dose calculation results that are generated to create a single 
patient plan. Beginning with the request for dose calculation by the end-user, the managing 
node first ingests the patient’s pre-treatment CT images and physician contour definitions 
(stored in DICOM RTStruct format) along with a list of beam specifications, and a 
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configuration file describing the machine-specific radiation delivery parameters, such as 
field of view and beamlet dimensions, as well as the type and energy of radiation to deliver. 
The remaining actions until the time when dose data is finally exported for treatment 
planning are all performed automatically and asynchronously from the user’s perspective. 
The sequence of actions performed by the managing server is specific to each treatment 
modality. For X-Ray RT, the sequence of actions includes the generation of an MC-compatible 
geometry file that will be supplied to the MC engine at execution, ray tracing to identify active 
beamlets, and the subsequent creation and enqueueing of new simulation tasks for every 
active beamlet. The managing node maintains a priority queue of simulation tasks that can 
be sent to a compute node for simulation when one becomes available. The placement of new 
simulation tasks into the queue depends on the user-specifiable priority setting, such that 
new high priority tasks are scheduled for simulation before already-enqueued tasks of lower 
priority. In the clinical setting, this functionality enables efficient planning amidst a setting 
in which patients’ schedules may change unexpectedly. In the research setting, this enables 
the user to enqueue many simulation tasks for long term studies such for generating training 
data for machine learning but still produce urgent results for short term studies in a timely 
manner. 
The managing node organizes all the plan configuration metadata and simulation task 
statuses in a local document-based database (MongoDB) with the hierarchical organization 
shown in Figure 4-1. Large data files such as dose calculation results and MC engine 
geometry inputs are stored on the native filesystem in a protected directory and linked into 
their corresponding database objects by their relative paths. Unique identifiers (UIDs) are 
assigned to each database object and are used to define a conflict-free directory hierarchy 
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on the filesystem. The primary database objects are classified as one of the Image, Structure, 
Beam, Sub-beam, Simulation, and Sample types. When a hierarchical relationship exists 
between two types, they are linked to one another by their UIDs. Organization of plan 
configurations in the database greatly simplifies structured retrieval of results using query 
filters; for example, dose calculation can be requested for one patient using two different 
treatment modalities and the results can be easily filtered and exported for direct 
comparison. 
 
Figure 4-1. Database document hierarchy. Simulations are organized as children of a sub-
beam (beamlet or spot). Sub-beams are children of a beam. Multiple beams can be defined for 
a single calculation geometry and multiple geometries can be defined for a CT image 
acquisition. Images contain masks for every structure defined in the RTStruct file. Simulations 
can produce one or more independent samples of dose for the same configuration as a method 
for machine learning dataset augmentation. 
All communication between the managing and compute nodes is performed using an 
efficient custom-defined protocol that operates over standard TCP/IP networking sockets. 
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Support for sending arbitrary files and JSON-serializable payloads is available. Every 
communication follows a standard for a request-response structure with optional payload 
in either direction. Both the requesting and responding nodes are aware of the 
communication status such that they can each require confirmation of receipt of their 
respective payloads if the application requires it. In addition to communication with 
compute nodes, a client interface was developed, allowing the user to interact with the 
managing node remotely. A RESTful API on the managing node interprets REST requests sent 
by the user via the client program to one of many possible actions, including Insertion of 
Image, Beam, Sub-beam, and Simulation objects into the database, extraction of beamlet dose 
for treatment planning purposes, and generation of anatomical structure masks. Using the 
endpoints of the REST API, the client interface can be easily modified to run user-defined 
scripts for performing various functions. End-to-end treatment planning can be added to the 
client interface as a user-facing command by chaining together the commands for defining 
the beams selected for the treatment, defining MC simulation tasks for the active sub-beams 
in each of the beams, exporting the dose calculation results as a sparse matrix suitable for 
treatment planning, and finally performing the inverse optimization to acquire the plan 
delivery parameters. Alternatively, deep learning dose datasets can be automatically 
generated by creating a script in the client interface that randomly selects beam angles, 
isocentre coordinates, and active beamlets from a set of patient images, then creates 
simulation tasks for each to run asynchronously until completion. Furthermore, the use of 
the REST API model for interaction ensures compatibility with a graphical web-based 
interface that would simplify the process of performing common tasks for the end-user, 
especially for clinical use. 
83 
4.2.2 Orchestration and Scalability 
To make deployment and scaling of our distributed MC simulation framework easier, 
Docker, a popular software containerization solution, was used. Docker functions similarly 
to a conventional virtual machine but differs in that instead of encapsulating an entire 
operating system (OS), which inefficient from both storage and processing perspectives, 
Docker interfaces with the existing OS at the kernel level, isolating the containerized 
software within the private network, filesystem, and process namespaces. The details of 
Docker’s implementation make it more lightweight on storage and processing overhead than 
virtual machines. Additionally, the contents and function of docker containers are defined by 
images, or snapshots of a virtual filesystem saved by its creator at a specific state – usually 
between when the targeted software is installed on the computer, and when it is finally 
executed. Images are composed as layers of changes to a base operating system, so if one 
base image is used to define multiple images, the base image will only be stored once and 
reused to reduce the total storage requirements. The primary benefit of Docker’s image-
based initialization is that a developer can configure the image such that all prerequisites are 
already installed at their intended versions, and the only thing left to do is run the target 
application. 
We created separate Docker images for the client interface, managing node process, and 
compute node process from a common base image that already contained the common 
libraries and python modules used by each process. Containerization of these processes 
allows fast deployment of the entire framework onto a user’s network with only a few simple 
commands. Furthermore, expansion to a larger pool of compute nodes is achieved simply by 
starting the compute node container on a new network-accessible computer and informing 
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the managing node of its network address. For even simpler deployment, Docker’s container 
orchestration tool (docker-compose) was used to make setup of the managing node and any 
number of compute nodes possible with a single command. Using container orchestration, it 
is updating all the framework code, across all involved nodes, can be achieved using a single 
command from the managing node. 
4.2.3 SimpleDose: A High-Level Treatment Planning Interface 
After our general-purpose MC framework was implemented, a simplified high-level user 
interface, named SimpleDose, was developed for extremely easy use in treatment planning 
workflows. In the general-purpose client interface, the user is free to select a managing node 
with which to issue commands and exchange data – useful when multiple teams on the same 
network each prefer to maintain their own databases. For simpler deployments, however, 
the generality of the framework makes user interaction more cumbersome, particularly in 
overcoming the learning curve associated with using Docker. The SimpleDose interface 
operates as a wrapper exposing only a subset of the functionality of the general-purpose 
client interface while completely hiding any details specific to using Docker. Among the 
features included in this interface were commands for automatically producing the beamlet 
dose data that were required by the treatment plan optimizer. The only manageable entity 
exposed by this interface, the plan object, consists of a patient CT image sequence, physician-
defined anatomical structure contours, the list of beams to be optimized in the plan, the 
treatment modality, and a set of parameters specific to the radiation delivery device. 
Through this interface, the end-user can easily add plans with custom priority, delete plans, 
view the simulation progress for each plan with additional descriptive information from the 
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plan, and export the simulated beamlet dose, anatomical structure masks, and beam 
descriptions - all required for treatment planning. 
4.3 Usage Examples 
Due to its ease of use, the high-level interface, SimpleDose, is the preferred way of 
interacting with the framework for the treatment planning setting. Figure 4-2 lists the 
commands provided by the SimpleDose interface.  
 
Figure 4-2. Summary of commands available from the SimpleDose interface for treatment 
planning dose calculation. 
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A typical planning workflow begins with the user exporting a CT image sequence and 
RTStruct file from their clinical radiology database. Next, a config.json file is created, 
indicating the name of the PTV structure, the beam modulation parameters (field of view and 
collimator dimensions), the desired dose voxel size (spatial resolution), treatment modality 
and beam energy spectrum, followed by the definition of the beamlist.txt file describing the 
angles and source-to-isocenter distances for every beam that will be considered in plan 
optimization. Finally, the create-plan command is run as demonstrated in Figure 4-3, which 
begins the automatically distributed MC dose calculation workflow. 
 
Figure 4-3. Create-plan command output using the SimpleDose to add dose calculation 
requests for automatically distributed computation. 
A plan-status command (Figure 4-4) is available, allowing the user to monitor the 
progress of dose calculation for each plan. The output is listed in a tabular format with 
various sorting options available. 
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Figure 4-4. Plan-status command output using the SimpleDose interface to list the 
simulation progress for all existing plans. 
For plans that have completed dose calculation, the plandose command is provided, 
which facilitates the export of planning dose data in a sparse format suitable for treatment 
plan optimization (in a format compatible for use as the matrix 𝐴  in Equation 2-4). To 
maintain flexibility with the preferred sparse matrix formats of a variety of computational 
linear algebra libraries, the coordinate list (COO) format is used for storing the exported 
planning dose data. The COO format uses three equal-length arrays to store the row index 
(voxel number), column index (beamlet number), and data value (voxel dose) for every non-
zero element of the represented matrix. The specification of this storage format is given in 
Figure 4-5. 
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Figure 4-5. Sparse storage format for calculated planning dose results for a SimpleDose plan. 
The sparse coordinate list (COO) format uses three equal-length arrays to store the row index, 
column index, and data value for every non-zero element of the represented matrix. 
4.4 Performance 
Our framework was installed on a private cluster and tested on its ability to accelerate 
large-scale MC beamlet dose simulation beyond the capabilities of a single node. Eight 
compute nodes were instantiated with a combined total of 216 logical CPU cores for use in 
large-scale MC beamlet dose calculation. IMRT plans for 20 electron beam treatment 
scenarios were submitted for beamlet dose calculation using the create-plan command of the 
SimpleDose interface with a total of 78,545 beamlets with dimensions varying between 1x1 
mm2 and 5x5 mm2. Each beamlet was simulated for 10,000 primary electron generations 
with an average time of 1.73 seconds per simulation. Using our framework, the total dose 
calculation time was 37.8 hours, constituting an average of 2,080 simulations per hour 
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(equivalently 20.8 million primary electrons per hour). By comparison, for MC dose 
calculation on one of the eight compute nodes with a total of 32 logical cores, the average 
rate of completion was approximately 310 simulations per hour (3.1 million primary 
electrons per hour), constituting a factor of acceleration approximately equal to 6.7, nearly 
equal to the theoretically expected factor of 6.75, with network transfer overhead suspected 
as responsible for the small deviation from theory. 
4.5 Conclusions 
Our distributed MC dose calculation framework provides a stop-gap solution to 
accelerating MC simulation in support of efficient research of novel treatment planning and 
dose calculation techniques. The scalability and ease of use of our framework make it a 
valuable tool for research applications spanning a large range of scales, while requiring little 
knowledge of dose calculation from the user. 
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5 DEEPMC: A DEEP LEARNING METHOD FOR 
EFFICIENT MONTE CARLO BEAMLET DOSE 
CALCULATION BY PREDICTIVE DENOISING IN 
MAGNETIC RESONANCE‐GUIDED 
RADIOTHERAPY 
5.1 Introduction 
Radiation therapy (RT) is one of the primary modalities for cancer treatment109. The 
success of RT hinges on the subtle balance between sufficient tumor doses and normal tissue 
toxicity. To attain the goal, one must perform tasks that include patient imaging, anatomic 
structure segmentation, optimization of plan delivery parameters, and validation of accurate 
radiation delivery. The availability of electron density and 3D anatomy for dose calculation 
and treatment planning provided by computed tomography (CT) have made it the imaging 
modality-of-choice in radiation therapy since its inception nearly 50 years ago.  CT-guided 
radiation therapy (CTgRT) has significantly advanced the accuracy of radiotherapy110,111,  
but its limitations in soft-tissue visualization, real-time monitoring, and harmful ionizing 
dose have been increasingly recognized. Motivation to overcome these challenges has led to 
a paradigm shift towards the use of magnetic resonance imaging (MRI), which affords better 
soft-tissue contrast, real-time tumor tracking, and eliminates the use of ionizing 
radiation112,113. These benefits are not without their caveats. Besides the lack of electron 
density information for radiation dose calculation, the strong magnetic field used by MRI 
perturbs dose deposition, causing significant inaccuracies in fast model-based dose 
calculation techniques developed for efficient CTgRT. 
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Image synthesis using generative adversarial networks (GAN) has provided a solution to 
assigning electron density to the MR images for dose calculation114,115. The second problem 
to significantly accelerate dose calculation without compromising accuracy for adaptive 
online radiotherapy (OART) 116–118 beamlet dose calculation remains unsolved. State of the 
art methods for calculating dose in the magnetic field-free condition employ deterministic 
convolution-based algorithms19,34,59,60,119,120, which are extremely efficient for handling a 
large amount of beamlet dose calculation34. These analytical methods reuse pre-calculated 
energy-specific dose deposition kernels, whose shift-invariance is violated by the Lorentz 
forces exhibited on electrons in a magnetic field. The resultant electron return effects (EREs), 
commonly observed at the interfaces between anatomies with large density gradients, have 
detrimental effects on the dose calculation accuracy to the patient121,122. Failing to account 
for EREs properly can generate disparities between expected and deliverable doses at these 
tissue-air interfaces in MRgRT by up to 70%123,124. On the other hand, the disparities can be 
mitigated with accurate EREs modeling in beamlet dose calculation125. 
An alternative method for calculating radiation dose is Monte Carlo (MC) simulation, 
which uses a probabilistic sampling of particle physics to simulate the transportation and 
dose deposition of primary X-rays and their child particles. Different from the analytical 
methods, MC is based on first principles without assuming shift-invariance that is violated 
with the magnetic field. Therefore, MC is better suited for MRgRT but substantially slower to 
simulate the number of particles needed for acceptably low statistical noise9 than the 
analytical methods. Besides conventional MC acceleration techniques9–11, efforts have been 
made to accelerate MC dose calculation using graphics processing units (GPUs) 15,16,126  for 
final plan dose calculation but the speed remains insufficient for the orders-of-magnitude 
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larger beamlet dose calculation task, which are critical to the OART and mitigation of 
undesirable EREs. The computational inefficiency of MC creates a bottleneck in time 
sensitive OART, where accurate beamlets need to be computed to mitigate EREs.  
In this work we present a novel deep learning-based MC post-processing framework, 
termed DeepMC, that employs deep convolutional neural networks (CNNs) as a complement 
to traditional MC acceleration techniques. Our approach enables meaningful acceleration of 
MC dose simulation for OART treatment planning purposes by predicting low-noise three-
dimensional (3D) dose deposition in the MRgRT setting from extremely noisy (but fast) MC 
simulation. Our dose prediction method distinguishes itself from traditional MC dose 
denoising approaches127–131 with its understanding of the dose deposition patterns learned 
from a population of diverse X-ray beam configurations and patient anatomies. As such, our 
method not only denoises, but reconstructs MR-guided dose deposition from a combination 
of regional noisy MC-simulated dose and anatomical cues for each newly observed X-ray 
beam. Our model is tasked with resolving the low-noise 3D dose deposition for each under 
sampled (high-noise) MC dose simulation. Distinctive from related works132,133, however, we 
confront the additional challenges of including 1.5T MRI magnetic field effects, as is the case 
for Elekta’s Unity MR-guided linac5, where Lorentz forces impose geometry-dependent dose 
perturbations as EREs, prediction at the finer beamlet-scale (5 mm width) instead of the full-
beam (~5-10 cm width), and more severe under sampling of the initial MC simulated dose 
(2,000 compared to 100,000 particles for high- and low-noise respectively).  
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5.2 Preliminary Investigation in Stacked Slab Phantom 
Geometries 
To demonstrate the proof of concept for an earlier, 2D version of our proposed DeepMC 
model (termed DeepMCv1), we conducted two experiments with limited data and generality. 
The experimental setup was identical for both: training and testing data sets consisting of 2D 
high- and low-noise dose image pairs were first synthesized using MC simulation, a model 
was developed and trained on the training data set, and the dosimetric fidelity to each low-
noise image was calculated for the high-noise (model input) and predicted (model output) 
images. The fidelity was measured using mean squared error (MSE) and the average gamma 
passing percentage of pixels for various gamma criteria across all samples in the testing data 
set. To gain more insight into the predictive performance, gamma index maps were 
visualized at certain intervals for random data samples as the model was trained. 
In the first experiment, a simple slab phantom was defined (Figure 5-1). From this basic 
phantom geometry, two material configurations were selected, yielding two distinct 
phantoms for study. The first phantom was designed with a water-to-lung, and a subsequent 
lung-to-water interface. The second was designed to produce more dramatic EREs by 
replacing water with aluminum and lung with air. For each of the virtual phantoms, a static 
1.5T magnetic field was defined perpendicular to the plane of beam angle variation. Dose 
was simulated for 45 beams spaced at three-degree increments between -66 and 66 degrees. 
Of these beams, eight equidistant beams were removed to a separate testing data set. Dose 
from each beam angle contained 18 slices that were separated and independently used for 
both training and testing. After training the model for two hours on four GPUs, the MSE 
between high and low-noise dose was compared with the MSE between DeepMCv1-
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predicted and low-noise dose. The predicted dose produced a reduction in average MSE by 
more than one order of magnitude on the full testing data set for both phantoms. Figure 5-2 
shows a longitudinal slice of dose for a beamlet in each phantom. The denoising effect of our 
approach is evident, and its ability to predict the ERE is promising. 
 
Figure 5-1. Slab phantom geometry specification for studying electron return effects present 
at high-density-gradient tissue interfaces. 
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Figure 5-2. MC dose ground truth (low-noise.), model input (high-noise) and DeepMCv1 
prediction for a photon beamlet in the low dose penumbra region (1.25cm off-axis) of 
water/air (left) and aluminum/air (right) slab phantoms. Lines indicate positions of 
horizontal material interfaces. Low-noise dose was simulated using 18M particles in ~3 
minutes. High-noise dose was simulated using 30K particles in 3 seconds. Prediction took 
<100ms after high-noise dose simulation. 
The proof of concept experiments conducted in slab phantoms with varying tissue 
compositions successfully demonstrated promise for our DeepMC dose prediction model to 
accurately reduce Monte Carlo dose calculation’s statistical noise while also reconstructing 
dose deposition concentrations at tissue interfaces affected by EREs. To continue this line of 
research, improvements to the model architecture were made and translation to patient 
treatment planning applications was investigated as described in the following sections. 
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5.3 Methods 
5.3.1 DeepMC Model Architecture 
To address the challenges of efficient MR-guided dose calculation, we’ve developed a 3D 
CNN (Figure 5-3) comprised of a UNet134 with three spatial feature scales, batch 
normalization135, residual136,137 and squeeze-excitation138 blocks, and ReLU activations139. 
Skip connections between matched spatial feature scales in the encoder and decoder halves 
of the UNet carry high resolution features through the network, preserving fine spatial dose 
detail in the final prediction. Learned stride-two convolution and stride-two transposed 
convolution are used for changing the spatial feature resolution between each UNet level. 
High-noise MC-simulated dose and CT number (as Hounsfield units) are passed in as two-
channeled 3D input to provide descriptive information for the model to learn to accurately 
predict dose containing EREs at the interfaces between high- and low-density anatomical 
media such as soft-tissue and internal airways. Our fully convolutional implementation 
further enables prediction of dose volumes with varying size140, granting flexible use during 
prediction of new cases. To guarantee matched feature map dimensions in both the encoder 
and decoder halves of the network for each spatial scale, the input data batch is zero-padded 
along each of the three physical dimensions, and later cropped to the original dimensions. 
The UNet section of our model is implemented at each spatial scale from a sequence of 
layer blocks. The blocks are composed of a 3D convolution with 1×1×1 kernels (for changing 
the feature map dimensionality), followed by three residual 3D convolution blocks with 3×
3×3 kernels (for spatial feature learning), and finally a squeeze-excitation block with a 
feature squeeze factor of four (to permit richer exploitation of inter-feature relationships 
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during prediction). Residual convolution blocks carry out batch normalization, followed by 
activation with the non-linear ReLU operation, and finally convolution. This “pre-activation” 
ordering in each block promotes better flow of information in deep networks when residual 
connections are included137. Downsampling in the UNet’s encoder half uses 3D convolution 
layers with 3×3×3 kernels and stride of two for all spatial dimensions. Upsampling, 
conversely uses 3D transposed convolution layers with 3×3×3 kernels and stride of two. The 
number of feature maps produced by each block is updated based on the spatial scales; the 
number of features is doubled each time the spatial resolution is halved, and the number of 
features is halved when the spatial resolution is doubled. We begin with 64 features 
produced in the first block at the full resolution scale. In the UNet’s decoder section, the 
output of each block is concatenated to the output of the corresponding block from the 
encoder section. The output of the UNet is processed by a 3D convolution layer with 1×1×1 
kernels to reduce the feature size to one, followed by a sequence of three residual 
convolution layers to perform the final dose prediction. 
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Figure 5-3. Fully convolutional model architecture used by our method, DeepMC. Numbers in 
blocks indicate number of feature channels produced by learned convolutional kernels at 
each stage. 3×3×3 kernels are used in UNet layers. 1×1×1 kernels are used for feature mixing 
and dose prediction. 
DeepMC is trained using the stochastic gradient descent algorithm with a batch size of 
30, a learning rate initialized to 0.03 and decayed along an exponential schedule tracking the 
number of iterations with a decay factor of 0.993. Training was performed in parallel on four 
NVIDIA GTX 1080 Ti GPUs for 50 epochs and lasted a total of 22 hours. Loss convergence 
curves are presented in Figure 5-4. 
 
Figure 5-4. DeepMC training progress. Per-epoch loss is shown for training dataset (grey) and 
validation dataset (orange). 
In Figure 5-5, a sample prediction at three consecutive axial slices for one beamlet is 
shown alongside the high-noise dose input and low-noise ground truth dose, such that both 
high- and low-dose regions of the beamlet are visible. Without including geometry 
information (CT Numbers), this is a challenging task for such aggressively under-sampled 
dose inputs, where estimations of EREs in the high-noise dose are otherwise masked by 
noise corruptions (arrows in Figure 5-5 indicate these corrupted areas in the high-noise 
dose).  
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Figure 5-5. Dose from low- and high-noise MC simulation and DeepMC prediction for one 
5x5mm2 x-ray beamlet. Three adjacent slices are shown with their transverse distance from 
the beamlet’s central axis listed in the titles. Color scale limits are displayed in the lower left 
corner for each slice in normalized units. Arrows show examples of electron return effects 
asymmetrically perturbing the dose deposition. High-noise simulation fails to accurately 
estimate dose in these areas while DeepMC dose matches the low-noise ground truth dose. 
Our model is implemented in the Python programming language using the TensorFlow 
v2.10 deep learning library141 and trained via supervised backpropagation using a weighted 
L2 loss on the voxel wise difference between DeepMC dose and low-noise ground truth dose. 
Beamlet dose suffers from severe data imbalance between the large number of low-dose 
voxels and the small number of high-dose voxels, which makes learning unstable. Figure 5-6 
shows the observed voxelized dose density and cumulative density. 
  
Figure 5-6. Observed density (left) and cumulative density (right) of voxelized x-ray dose, 
normalized to per-beamlet maxima. Voxels with dose lower than 10% of per-beamlet maxima 
account for over 99% of observations. Vertical axes are displayed in log-scale. 
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To address this imbalance in the data distribution, we defined a voxel wise decaying 
exponential loss weighting function, shown by Equation 5-1 for ground truth dose volume 𝑌 
and prediction ?̂? , that assigns unitary weight to voxels with dose equal to the maximum 
ground truth dose for each beamlet, and decays for smaller values. 
𝑊(𝑌) = exp [−𝛼 ⋅ (1 −
1
2
(?̂?+𝑌)
max(𝑌)
)]. 
Equation 5-1 
The exponential decay factor, 𝛼, is a configurable hyperparameter for which we found 𝛼 
equal to 3.0 to be empirically effective in stabilizing the training progress and achieving 
accurate and generalizable predictions. 
5.3.2 Dose Data Generation 
For MRgRT dose calculation, both the high-noise dose (model input) and low-noise dose 
(ground truth) are calculated using stochastic MC simulation methods, granting a physically 
accurate method of generating virtually unlimited data. Although we can theoretically 
continue to synthesize data pairs until model performance on a separate testing dataset 
converges to the ground truth, we are burdened by the slow speed of MC simulation using 
modern software. Our task of calculating x-ray dose for MRgRT poses the added challenge of 
modeling the complex geometry-dependent physics induced by EREs. While the more 
traditional setting of CT-guided radiotherapy has benefited remarkably from 
implementation on graphics processing units (GPUs), similar attempts to realize such 
hardware-enabled levels of acceleration in the MR-guided setting have been largely 
unsuccessful. The Monte Carlo simulation framework, Geant4142,143, used in this study was 
selected for its accuracy and flexibility in simulating dose for MRgRT, but as a central 
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processing unit (CPU)-based particle simulation toolkit, it is too slow for direct clinical use 
in OART. Simulation on a single CPU core, for a few thousand particles to produce highly 
corrupted high-noise dose is relatively fast, on the order of seconds for a single beamlet. On 
the other hand, the time to simulate the hundreds of thousands of particles necessary to 
produce low-noise dose is on the order of minutes. Linear improvements in simulation speed 
are attainable by enabling Geant4’s multi-threaded parallel processing capability to make 
use of every core of the CPU. For clinical OART and for the purposes of generating data to 
train our CNN model this is still too slow. 
To address these speed concerns, we developed an automated and distributed simulation 
framework that uses a communication model consisting of a single manager node assigning 
tasks to one or more worker nodes for asynchronous and scalable computation divided at 
the unit of individual beamlets. We developed a protocol for sending beamlet simulation 
tasks to any available worker on the network and receiving the simulated dose for retrieval 
during model training. Docker containerization is used to simplify the setup of new workers. 
The manager connects with a central database to identify remaining tasks and organize 
completed task results. Using this framework, we expanded the multi-threaded processing 
functionality of Geant4 to operate over a scalable pool of network-accessible computational 
nodes with ease. For our purposes, a cluster of 10 nodes and a combined total of over 160 
logical CPU cores was utilized to generate training and testing datasets in condensed 
timeframe.  
The training dataset consists of 56,000 paired beamlet dose volumes in total; the high-
noise dose was simulated using 2,000 particles per beamlet and the low-noise (ground truth) 
dose for each beamlet was simulated independently for 100,000 particles. A set of 2,400 
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randomly selected coplanar beam angles and translations (≤4mm radius) from the planning 
target volume (PTV) centroid were defined from each of eight retrospectively collected Head 
and Neck (H&N) pre-treatment CT scans containing expert-defined clinical anatomic 
delineations. Since we would like to produce a general model for prediction of low-noise 
dose, we not only benefit from the simplicity of randomly selecting the beamlet geometries 
for training, but additionally produce a dataset exhibiting greater geometric diversity. Rather 
than limiting training to only the most common beamlet orientations, such as those sourced 
from historical clinical treatment plans, a generality is maintained in the scope of beamlet 
orientations for which dose can be accurately predicted when creating new plans. 
Additionally, efficient five-fold data augmentation was achieved with low additional cost 
by pairing a single low-noise dose volume with each of five independently simulated high-
noise dose volumes – justified by the stochastic nature of MC simulation up to a limit in the 
number of simulated particles9. Simulation of the common low-noise dose for each beamlet 
uses enough particles to approach a deterministic solution with negligible noise corruption, 
whereas simulating five low-noise dose volumes instead produces five effectively identical 
dose output at five times the computational cost. Furthermore, for the faster high-noise MC 
simulations, much of the runtime is spent on initialization of the particle interaction 
probability tables and simulation geometry. Data augmentation by repeated high-noise 
simulation of one geometric configuration amortizes the fixed initialization cost across 
multiple results, minimizing the overall computational cost for training data generation. We 
have access to the exact geometric parameters of each of our generated beamlet 
configurations during both training and prediction. This property of the task is exploited to 
remove unnecessary training complexity by standardizing the beamlet orientations with 
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simple 2D rotation. This guarantees that every beamlet seen by the model has the same 
orientation, simplifying the latent understanding that the model must learn.  
An independent testing dataset was generated by calculating high- and low-noise dose 
pairs for 8,043 active beamlets selected to enable creation of a clinical IMRT plan for two 
separate H&N patients, withheld during model training. For the first patient, seven beams 
were equally distributed in a 360-degree ring around a single isocenter, placed at the PTV 
centroid. In the second, six and seven beams were distributed around two disjoint PTVs, 
respectively. 
5.3.3 Experiment Design 
To validate our approach to MC dose prediction, we performed two types of evaluation. 
First, we trained our proposed model using paired high- and low-noise MC dose volumes, 
generated using our distributed simulation framework. DeepMC dose predictions were then 
produced alongside the paired high- and low-noise MC dose for each of the training and 
testing beamlet configurations. Normalized mean absolute error (NMAE) was calculated 
between the high-noise dose (model input) and low-noise ground truth dose, and again 
between the DeepMC-predicted dose and the low-noise ground truth dose. Maximum low-
noise ground truth dose for each beamlet served as the normalization reference. Comparing 
the two NMAE values indicates the overall improvement of dosimetric accuracy achieved by 
using our prediction model instead of the high-noise MC dose directly.  
A clinically motivated analysis was then performed to evaluate DeepMC’s ability to 
calculate the beamlet dose for effective treatment planning. First, DeepMC dose was 
predicted for every active IMRT beamlet in each of two testing dataset H&N CT scans. 
Deliverable treatment plans were created by optimizing plan delivery parameters (x-ray 
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fluence, i.e. the quantity of x-rays to emit  per unit area of each beam) according to a 
previously formulated convex optimization problem36 presented in Equation 5-2. 
minimize
𝑓
  
1
2
‖𝑊(𝐴𝑓 − 𝑑0)‖2
2
⏟            
Dose Fidelity
+ 𝜆 (‖𝐷𝑥𝑓‖1 + ‖𝐷𝑦 𝑓‖1)⏟              
Anisotropic Total Variation
subject to 𝑓 ≥ 0.
 
Equation 5-2 
𝐴 is the planning dose matrix with vectorized 3D dose for each beamlet occupying a 
column, 𝑑𝑜  is the ideal vectorized 3D dose deposition prescribed by the physician and 
further informed by organ-specific radiation dose tolerances, 𝑊  is a diagonal matrix 
encoding the anatomical-structure-specific dose goal importance, 𝑓  is the optimization 
variable encoding the per-beamlet x-ray fluence, and 𝜆 , 𝐷𝑥, and 𝐷𝑦 are the term weighting 
and first-order finite differencing operators for the 𝑥- and 𝑦-axes of the beam-specific two-
dimensional (2D) fluence maps encoded in 𝑓, respectively. The first term encourages the 
planned dose to match the physician-prescribed dose, while the second term encourages the 
optimal 2D fluence maps to be smooth and, therefore, more efficient to deliver. The convex 
optimization problem in Equation 5-2 is solved using the Fast Iterative Shrinkage 
Thresholding Algorithm (FISTA)46, by which 𝑓 is iteratively updated until convergence to the 
global minimizer (𝑓∗) of the objective function while obeying the non-negativity constraint.  
Plans were optimized using three methods for pre-calculating 𝐴: low-noise ground truth MC 
simulation (𝐴𝐺𝑇 ), high-noise MC simulation (𝐴𝑁𝑜𝑖𝑠𝑦 ), and our model’s dose prediction 
(𝐴𝐷𝑒𝑒𝑝𝑀𝐶); these plans will be hereafter referred to as ground truth, noisy, and DeepMC, 
respectively. The plans were designed such that the planning target volume (PTV) receives 
a uniform dose equal to the prescription dose. Additionally, the dose to each organ-at-risk 
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(OAR) was reduced as much as possible by adjusting the importance weightings in 𝑊while 
optimizing the ground truth plan, then holding  𝑊 constant to optimize the other two (noisy, 
DeepMC) plans, for unbiased comparison. Plan normalization was performed after 
optimization to set D95 (5th percentile of dose) of the PTV to the prescription dose.  
After optimizing each plan, the product 𝐴𝑓∗  gives an efficient dose estimate (termed 
planning dose) with which the clinical dosimetrist evaluates the plan quality for approval 
prior to radiation delivery. After approval, 𝐴𝐺𝑇 is then used to calculate the deliverable dose 
for each plan, which is a higher quality indication of the eventual dose delivery. Due to the 
associated cost of computing 𝐴𝐺𝑇  with low-noise MC simulation, in a clinical planning 
timeframe the deliverable dose is calculated only after a plan has first been approved from 
its planning dose. We investigate both the error in the observable plan dose (planning vs. 
deliverable) as well as the deliverable plan quality differences generated by each dose 
approximation during optimization (noisy and DeepMC vs ground truth). We adopt a 
standard clinical procedure for plan evaluation that analyzes characteristics of dose volume 
histogram (DVH) curves for each PTV and OAR structure and compares various plan quality 
metrics quantifying first order dose statistics, uniformity, and coverage. Included in this 
analysis are the D1, D2, D98, D99 (99th, 98th, 2nd, and 1st percentiles of dose), mean dose, 
maximum dose, homogeneity index (HI)144, describing the uniformity of dose within the PTV, 
and conformity number (CN)145, describing the compactness of dose to control dose spillage 
beyond the PTV.  
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5.4 Results 
DeepMC dose (high-noise dose, respectively) from the testing dataset has NMAE 1.253e-
3 (2.775e-3). Ignoring voxels with less than 10% of the maximum dose for each beamlet, the 
NMAE is 3.960e-2 (9.724e-2). Prediction times were 26 ms per beamlet, amortized over 
batches of 30 beamlets on a single NVIDIA 1080Ti GPU. High-noise (low-noise, respectively) 
simulation required 1.76 s (86.35 s) per beamlet on one CPU thread. Utilizing a more 
clinically realistic computing platform with an Intel i9-7900X CPU featuring 20 logical cores 
and 1 NVIDIA GTX 1080Ti GPU, high-noise MC simulation and subsequent DeepMC 
prediction for the IMRT plans of the two testing patients, which modulated 2,111 and 5,932 
beamlets, respectively, was achieved in clinically feasible times of 241 s and 658 s compared 
to 9,114 s and 24,899 s required by noise-free MC simulation. 
Figure 5-7 compares deliverable dose DVHs for the ground truth, DeepMC, and noisy 
plans. Plans for the first testing patient (Figure 5-7 top) targeted a single PTV with a 
prescription dose of 70 Gray (abbreviated as Gy). PTV dose for the DeepMC plan shows 
better agreement with ground truth than the noisy plan, particularly in the high-dose region 
(lower right curve segment). OAR dose for the DeepMC plan displays smaller error with 
ground truth than the noisy plan, especially in the spinal cord, left cochlea, both 
temporomandibular joints (TMJs), and both parotid structures. The plans for the second 
testing patient (Figure 5-7 bottom) targeted two PTVs with prescribed doses of 54 Gy and 
59.4 Gy and a boosted internal volume of the second PTV to 70 Gy. As in the first testing 
patient, deliverable PTV dose for the DeepMC plan agrees more closely with the ground 
truth, especially in the high dose region of the 70 Gy PTV. For the 54 Gy and 59.4 Gy PTVs, 
the DeepMC plan shows cold spots, observed as lower curves at the “knee” immediately 
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before the steeply downward-sloping portion of the curve. Agreement of OAR dose for the 
DeepMC plan with the ground truth plan is better than the noisy plan, particularly in the 
larynx, spinal cord, right parotid, and left temporomandibular joint.  
 
 
Figure 5-7. Dose volume histogram comparing “deliverable” dose for IMRT treatment plans 
created using low-noise ground truth, DeepMC-predicted, and high-noise beamlet dose for 
testing patient one (left) and two (right). Doses for all plans are recalculated after plan 
optimization using low-noise beamlet dose to reflect the deliverable dose to each patient. 
Figures 5-A1 through 5-A4 compare planning and deliverable dose for the noisy and 
DeepMC plans. Differences are larger between planning and deliverable PTV dose for the 
noisy plan than the DeepMC plan, indicating improved planning accuracy using DeepMC-
predicted vs. high-noise beamlet dose. Better agreement of both planning and deliverable 
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dose for the DeepMC plan to the ground truth plan substantiates this advantage over the 
noisy plan. The pronounced differences seen in the planning dose (Figure 5-A2 and Figure 
5-A4) for both testing patients indicate that during the evaluation of the noisy plan in a 
clinical setting (via the planning dose), it would be rejected for failing to meet the PTV dose 
goals prescribed by the physician, while DeepMC plans (Figure 5-A1 and Figure 5-A3) match 
the ground truth plan in quality and would, therefore, pass clinical evaluation. 
Table 5-1 presents the clinical plan quality metrics for PTV and OAR structures from the 
deliverable dose for each of the first testing patient’s plans. Table 5-B1 presents the same 
metrics for the second testing patient. Dose is listed in units of Gy. Conformity number (CN) 
is unitless, with unity being ideal. The homogeneity index is unitless as well, with lower 
values indicating better dose homogeneity. 
Table 5-1. Plan quality metrics derived from deliverable dose to the first testing patient for 
plans optimized using different beamlet dose calculation methods. 
 𝑫𝒎𝒆𝒂𝒏  𝑫𝒎𝒂𝒙  PTV Dose Metrics 
Structure GT Noisy DeepMC  GT Noisy DeepMC  Metric GT Noisy DeepMC 
PTV (70Gy) 74.19 76.20 74.43  83.39 91.90 84.87  𝐶𝑁 0.79 0.78 0.79 
Body 10.89 11.74 10.92  83.39 91.90 84.87  𝐻𝐼 0.15 0.23 0.18 
Brain 6.24 6.53 6.16  73.77 79.40 74.06  𝐷1 78.08 83.98 79.94 
Brainstem 32.10 32.18 31.89  70.56 70.43 74.06  𝐷2 77.54 82.97 79.15 
Spinal Cord 4.81 5.45 4.69  34.75 36.64 33.01  𝐷98 67.14 67.16 66.89 
Chiasm 18.09 23.75 16.79  44.57 61.41 42.06  𝐷99 65.14 65.29 64.70 
R TMJ 45.45 52.61 46.37  65.90 72.49 65.13      
L TMJ 21.46 30.56 26.55  26.72 38.53 31.63      
R parotid 20.75 26.98 21.24  48.69 60.00 51.82      
L parotid 15.32 19.51 15.73  29.85 45.88 38.52      
R cochlea 58.80 62.37 60.86  69.93 71.81 71.39      
L cochlea 20.95 26.14 21.66  26.39 33.24 29.26      
Pharynx 18.61 18.56 18.49  70.88 73.21 72.47      
Absolute dose is presented in units of Gy. Plans with best agreement to ground truth for each 
metric and structure are shaded green. 
The deliverable dose for the DeepMC plan PTV 𝐷𝑚𝑒𝑎𝑛 and 𝐷𝑚𝑎𝑥  are closer to the ground 
truth plan, with 0.3% (0.24 Gy) and 1.8% (1.48 Gy) error, than the noisy plan, with 2.71% 
(2.01 Gy) and 9.11% (8.51 Gy), respectively. Similarly, most OARs show deliverable dose that 
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best agrees with the ground truth plan when DeepMC beamlet dose rather than high-noise 
beamlet dose is used for plan optimization. The plan with lower error compared to ground 
truth is indicated by green fill for each structure in Table 5-1.  
Axial dose color wash slices at the center of the PTV for the first testing patient are 
presented in Figure 5-8 and Figure 5-9 (and for the second testing patient in Figure 5-C1 and 
Figure 5-C2). Figure 5-8 and Figure 5-C1 compare the deliverable dose of noisy, DeepMC, 
and ground truth plans. Dose differences for the noisy and DeepMC plans compared to the 
ground truth plan demonstrate the changes in dose deliverable to the patient when using 
their respective dose calculation techniques. Differences in the deliverable dose for the noisy 
plan compared to the ground truth plan are greater in magnitude than for the DeepMC plan, 
depicted as regions of dark red and blue.  
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Figure 5-8. Deliverable dose color washes for axial slices from the first testing patient. 
Deliverable dose for each plan is recalculated using low-noise beamlet dose after plan 
optimization. The last two columns show differences in deliverable dose attributed to using 
either high-noise or DeepMC-predicted dose approximations to optimize IMRT beamlet 
fluence. Colors scales are consistent for each row; scale limits shown on the color bar in 
absolute dose units of Gy. 
Figure 5-9 and Figure 5-C2 compare the planning dose with the deliverable dose for each 
beamlet dose calculation strategy. Dose difference slices labeled as ΔNoisy and ΔDeepMC 
show regions where the efficiently-calculated estimate of the plan quality (planning dose) 
deviates from the true plan quality (deliverable dose), which is considered as the true dose 
delivered to the patient if using the optimized X-ray fluences in each scenario. ΔNoisy reports 
a global noise corruption in the planning dose estimate matching the noise signature of high-
noise MC dose. ΔDeepMC shows that it’s planning dose slightly overestimates the anterior 
PTV dose and underestimates the posterior PTV, but the magnitude of error in planning dose 
is substantially lower than that of the noisy plans. 
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Figure 5-9. Planning and deliverable dose color washes for axial slices from the first testing 
patient. Planning dose is used directly for plan optimization. Deliverable dose for each plan is 
recalculated using low-noise beamlet dose after plan optimization. The Last two columns 
show differences in planning and deliverable dose for each plan. Color scales are consistent 
for each row; scale limits shown on the color bar are in absolute dose units of Gy. 
Figure 5-10 and Figure 5-D1 reveal the treatment delivery parameters (per-beamlet 
fluence) resulting from optimization for each plan. For both testing patients, optimization 
using DeepMC beamlet dose converges upon a set of plan parameters that agree more closely 
with the ground truth parameters than optimization using high-noise beamlet dose. This 
suggests that high-noise beamlet dose leads to a very different delivery of X-rays than low-
noise beamlet dose, while the DeepMC beamlet dose enables optimization to arrive at the 
ground truth plan delivery parameters. 
 
Figure 5-10. Plan delivery parameters (X-ray beamlet fluence) for the first testing patient 
resulting from optimization using DeepMC, high-, and low-noise beamlet dose. All color scales 
are consistent, and limits are shown in the color bars on the right. All are normalized to the 
per-beam maximum fluence from the ground truth plan. 
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5.5 Discussion 
DeepMC using a single logical CPU core and one GPU enables acceleration of end-to-end 
MC simulation and prediction by a factor of 48.4, approaching the theoretical limit of 50 set 
by the ratio of primary x-rays simulated for high- (2,000 particles) and low-noise (100,000 
particles) dose. For a more realistic local computing environment with 20 logical CPU cores 
and 1 GPU, the effective acceleration factor enabled by end-to-end DeepMC dose calculation 
is 37.8, due to the efficiencies in both high- and low-noise MC simulation gained from CPU 
multithreading. Using only these modest local computational resources, end-to-end DeepMC 
dose calculation for fixed-beam online-adaptive IMRT planning was enabled in clinically 
feasible time of under 11 minutes instead of the prohibitive time of 6.9 hours required of 
traditional low-noise MC dose calculation. Utilizing additional CPU cores for high-noise MC 
simulation reduces the fraction of time for MC relative to DeepMC-prediction. Conversely, 
using additional GPUs for DeepMC-prediction increases the acceleration factor and gives 
end-to-end DeepMC dose calculation a greater speed advantage over low-noise MC 
simulation. Additional work is necessary to fully characterize the performance-cost trade-
offs and determine the optimal ratio of CPU to GPU resources for realize maximum 
acceleration; this will be the focus of future work.  
Note that even with high-noise dose calculation, MC alone consumes 99% of the total 
planning time, due to the much greater relative efficiency of modern plan optimization 
algorithms. Geant4 as the MC engine without additional acceleration techniques such as 
variance reduction is known to be relatively slow. On the other hand, conventional MC 
acceleration techniques alone are inadequate, particularly for larger planning problems, 
such as beam orientation optimization38,43 and volumetric modulated arc therapy40,41 that 
113 
involve two to three orders of magnitude more beamlets. DeepMC can be readily combined 
with these conventional techniques to provide additional acceleration by 38-fold on modest 
local computational resources. Combining additional distributed computational nodes with 
our scalable distributed MC simulation framework, the total DeepMC dose calculation time 
can be further reduced, enabling more complex and beneficial planning paradigms (with 
greater demands on dose calculation) within the clinically feasible timeframe. 
In recent years, deep learning has made strides in image processing, classification, and 
prediction. Its medical applications have met two common roadblocks: the availability of 
training data and the interpretability of the results. The current task is minimally affected by 
these roadblocks. Instead of relying on limited, laboriously curated patient images, a diverse 
training data set of paired of low- and high-noise dose volumes can be almost infinitely 
produced via MC simulation from a relatively small number of collected patient images. 
Distinct from MC dose denoising methods that use restrictive imaging filters, the mechanism 
of DeepMC is established on the physical processes of particle transportation in the presence 
of the magnetic field and with knowledge of the underlying anatomy. Therefore, DeepMC is 
more effective than an imaging denoiser because it operates from a mechanistic 
understanding of the dose deposition process, learned from a diverse population of 
examples. 
Treatment plan parameters determined by optimization with DeepMC-predicted 
beamlet dose showed better agreement with those produced using ground truth (low-noise) 
MC simulated beamlet dose, indicating that DeepMC is more clinically useful for treatment 
planning than high-noise MC simulation, with little additional cost. Lower error between 
planning and deliverable dose for DeepMC compared to noisy plans indicates that DeepMC 
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planning dose is a more reliable estimate of deliverable dose, while high-noise planning dose 
produces treatment plans that the planning dosimetrist would likely reject before the more 
costly deliverable dose is calculated. DeepMC plans featured substantially reduced OAR 
mean and maximum doses and superior PTV conformity and coverage, with better 
agreement to the ground truth plans, for both testing patients. 
Although the current study is for a specific MRgRT problem, our method can be 
generalized to other areas that benefit from or are enabled by faster MC calculation. Within 
radiotherapy, the accuracy of proton and heavy ion therapy planning has also been 
hampered by slow MC dose calculation146. For cone-beam CT, estimation of scattered x-rays 
with MC is effective for reducing imaging artifacts from iterative reconstruction, but is 
prohibitively slow for online applications147. In the wider scope of computer graphics, MC 
optical ray tracing for photorealistic scene rendering is now used extensively for final 
rendering of cinematic animation and visual effects148 but is currently too slow for high 
quality and noise-free interactive use and real-time applications such as live action 
environment generation149 and interactive virtual and augmented reality experiences where 
more efficient but less realistic rendering approaches are commonplace.  
5.6 Conclusions 
Fast and accurate beamlet dose calculation is essential to the success of online adaptive 
MRgRT accounting for the actual anatomical configuration and EREs. For effective OART, we 
use a novel deep learning method that substantially accelerates the accurate but traditionally 
slow MC dose calculation process. We then performed an end-to-end test to create and 
evaluate clinical IMRT plans with the novel dose calculation method. Treatment plans 
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optimized with DeepMC-predicted beamlet dose have plan delivery parameters and 
deliverable dose closely matching the ground truth plan, with substantially lower 
computational time. In comparison, the direct utilization of high-noise MC beamlet dose 
instead produces an unacceptable deviation in the deliverable dose from the planning dose. 
DeepMC offers relief to the computational costs of MC simulation for a wide scope of 
applications, enabling new technologies in many new areas. 
116 
5.7 Appendices 
5.7.1 Appendix A. Dose Volume Histograms 
  
(5-A1) (5-A3) 
  
(5-A2) (5-A4) 
Figures 5-A1 through 5-A4. Dose volume histograms for treatment plans created using 
DeepMC-predicted (top) and high-noise MC-simulated (bottom) beamlet dose. Ground truth 
plans are created using low-noise MC-simulated dose. Dose for “planning” curves is calculated 
using each plan’s respective beamlet dose after plan optimization. Dose for “deliverable” 
curves is recalculated using low-noise dose for more accurate, but more computationally 
expensive plan quality evaluation. 
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5.7.2 Appendix B. Plan Quality Metrics 
Table 5-B1. Plan quality metrics derived from deliverable dose to the second testing patient 
for plans optimized using different beamlet dose calculation methods. 
 𝑫𝒎𝒆𝒂𝒏  𝑫𝒎𝒂𝒙   PTV Dose Metrics 
Structure GT Noisy DeepMC  GT Noisy DeepMC   Metric GT Noisy DeepMC 
PTV #1 (54Gy) 57.17 57.91 56.96  72.77 71.06 72.86  
5
4
 G
y
 CN 0.19 0.18 0.17 
PTV #2 (59.4Gy) 63.34 64.35 63.72  80.80 85.56 85.05  HI 0.26 0.31 0.31 
PTV #2 (70Gy) 74.96 76.54 74.90  83.43 89.35 87.60  𝐷2 62.40 64.88 63.76 
Body 8.82 9.16 8.75  77.75 78.72 81.86  𝐷98 48.27 48.22 46.87 
Brain 0.76 0.76 0.76  56.60 58.62 56.90       
Brainstem 5.52 5.79 5.35  40.49 42.22 38.54  
5
9
.4
 G
y
 CN 0.41 0.40 0.39 
Spinal Cord 17.96 21.29 17.87  40.14 45.68 40.48  HI 0.41 0.45 0.44 
R TMJ 8.44 8.97 7.50  17.70 18.56 17.39  𝐷2 73.63 76.20 74.66 
L TMJ 20.89 20.56 22.04  38.30 35.64 39.96  𝐷98 49.37 49.22 48.33 
R parotid 23.09 25.36 22.93  58.95 63.06 58.71       
L parotid 31.47 33.31 31.96  59.93 61.87 58.73  
7
0
 G
y
 CN 0.78 0.70 0.73 
R cochlea 0.99 1.05 0.95  1.63 1.72 1.56  HI 0.17 0.23 0.19 
L cochlea 2.46 2.49 2.53  4.41 4.39 4.55  𝐷2 79.04 83.57 80.32 
Larynx 25.10 27.74 24.80  63.23 62.45 61.45  𝐷98 67.29 67.41 67.34 
Pharynx 44.53 46.19 45.30  67.97 72.53 69.79       
Absolute dose is presented in units of Gy. Plans with best agreement to ground truth for each 
metric and structure are shaded green. 
5.7.3 Appendix C. 3D Dose Comparison 
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Figure 5-C1. Deliverable dose washes for axial slices from the second testing patient. 
Deliverable dose for each plan is recalculated using low-noise beamlet dose after plan 
optimization. The last two columns show differences in deliverable dose attributed to using 
either high-noise or DeepMC-predicted dose approximations to optimize IMRT beamlet 
fluence. Colors scales are consistent for each row; scale limits shown on the color bar in 
absolute dose units of Gy. 
 
Figure 5-C2. Planning and deliverable dose color washes for axial slices from the second 
testing patient. Planning dose is used directly for plan optimization. Deliverable dose for each 
plan is recalculated using low-noise beamlet dose after plan optimization. The Last two 
columns show differences in planning and deliverable dose for each plan. Color scales are 
consistent for each row; scale limits shown on the color bar are in absolute dose units of Gy. 
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5.7.4 Appendix D. Fluence Map Comparison 
 
Figure 5-D1. Plan delivery parameters (X-ray beamlet fluence) for the second testing patient 
one resulting from optimization using DeepMC, high-, and low-noise ground truth beamlet 
dose. All color scales are matched consistent, and limits are shown in the color bars on the 
right. All are normalized to the per-beam ground truth maximum fluence from the ground 
truth plan. 
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6 SUMMARY OF WORK 
Dose calculation speed is a matter concerning the full spectrum of radiation treatment 
paradigms, especially those at the cutting-edge for which slow dose calculation has barred 
translation from research to clinical application. This work focuses on identifying 
applications of clinical radiation dose calculation that, until now, were not suitably fast to 
accommodate more advanced, and more computationally expensive, planning approaches. 
To these applications, principles of high performance computing and machine learning were 
applied in order to provide substantial acceleration to the dose calculation process, affording 
more time to advanced forms of planning with access to more causal dose information than 
previously achievable in the same timeframe. 
The widely used CCCS algorithm, relied upon for a large fraction CT-guided X-ray 
treatment planning, was first investigated. A novel approach for the implementation of CCCS 
dose calculation on GPU hardware took advantage of the compact deposition of dose 
surrounding narrow X-ray beamlets to parallelize the calculation across hundreds of 
beamlets at once. This context-based GPU-CCCS method realizes higher utilization of GPU 
hardware, offering two to three orders of magnitude of acceleration compared to existing 
implementations of CCCS on GPU hardware. Further improvements to acceleration with 
near-linear scaling in performance were demonstrated via a distributed, multi-GPU 
framework, offering flexibility of use to a wide variety of applications. 
Next, a focus on accelerating large-scale MR-guided X-ray dose calculation resulted in the 
development of an automatically distributed and scalable framework for MC dose 
calculation. The framework was implemented using Docker, a software containerization and 
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orchestration tool, making it simple to install and scale across a new user’s network of 
computational nodes. A low-level user interface was developed, allowing scripted 
manipulation of a database of simulation task definitions and structured exporting of 
calculated doses. A high-level interface, SimpleDose, was also developed to conceal Docker-
specific details of usage for greater ease. SimpleDose was tested on a cluster of 8 nodes and 
a combined total of 216 CPU cores, offering a simulation rate of approximately 21 million 
primary particles per hour, for near theoretical performance scaling, 
The distributed MC simulation framework offers a stop-gap solution to very-large-scale 
dose calculation for accelerating radiotherapy research but remains too slow for the 
extremely demanding clinical application of MR-guided OART. To simultaneously reduce the 
MC dose calculation time and benefit from existing MC acceleration techniques, a deep 
convolutional neural network (CNN) approach was developed to predict low-noise dose 
from substantially undersampled, noisy MC-simulated dose. The distributed MC framework 
was utilized to generate a large dataset of paired high- and low-noise doses for model 
training, and the feasibility of using DeepMC for OART treatment planning was demonstrated 
for two clinical H&N patients with IMRT dose calculation times under 11 minutes, for a 38-
fold acceleration compared to conventional low-noise MC dose calculation. Additionally, 
DeepMC has potential for application in other treatment modalities such as proton and 
heavy-ion therapy where MC dose calculation is common-place and cumbersome to the 
treatment planning process. 
This work defines new expectations on the speed of radiation dose calculation time that 
enable clinical translation of several beneficial new paradigms in radiation therapy. The 
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focus on scalable techniques for dose calculation make the proposed approaches applicable 
to the full gamut of treatment scenarios. 
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